The present description relates generally to a notification system, and more particularly, but not exclusively, to a context-aware healthcare notification system.
Healthcare facilities, such as hospitals, may utilize many different user devices, healthcare devices, and/or healthcare systems to facilitate with providing healthcare to patients. For example, a healthcare facility may utilize healthcare systems to facilitate with providing healthcare to patients, such as through physician order entry systems, pharmacy information systems, hospital information systems, etc. The healthcare facility may also utilize healthcare devices to facilitate with providing healthcare to patients, such as infusion devices, dispensing devices, respiratory devices, etc. In addition, the healthcare facility may utilize user devices to facilitate with providing healthcare to patients, such as computing stations that are located throughout the health facility, personal digital assistants (PDAs) that are carried by health care professionals, etc. However, the healthcare facility may be unable to provide relevant information from the healthcare systems and healthcare devices to the user devices in a timely manner.
The disclosed subject matter relates to a user device for facilitating healthcare. The user device may include a processor and a memory. The memory may include instructions that, when executed by the processor, cause the processor to: determine when the user device is within proximity of at least one healthcare device, receive information pertaining to the at least one healthcare device when the device is within the proximity of the at least one healthcare device, and display at least a portion of the received information.
The disclosed subject matter also relates to a user device for facilitating healthcare that includes a wireless interface, a receiver, a processor, and a display. The wireless interface may be configured to determine when the user device is located within a proximity of a patient. The receiver may be configured to receive information related to the patient when the user device is located within the proximity of the patient. The processor may be configured to determine whether the information indicates that corrective action is required. The display may be configured to display at least a portion of the information when the information indicates that corrective action is required.
The disclosed subject matter also relates to a method for providing for providing context sensitive information to a user device. The method includes determining, by a user device, that the user device is within a proximity of a patient or a healthcare device. The method further includes receiving, by the device, information that relates to the patient or the healthcare device and determining, by the device, whether the information indicates that corrective action is required or a safety issue exists. The method further includes displaying, by the device, at least a portion of the information when the information indicates that the corrective action is required or the safety issue exists.
The disclosed subject matter also relates to a system. The system includes one or more processors and a memory. The memory includes instructions that, when executed by the one or more processors, cause the one or more processors to: determine when a user device is within a proximity of at least one healthcare device or at least one patient, receive first information related to the at least one healthcare device or the at least one patient from a plurality of healthcare systems over a communication network, when the user device is determined to be within the proximity of the at least one healthcare device or the at least one patient, and transmit, to the user device over the communication network, at least a portion of the first information related to the at least one healthcare device or the at least one patient.
It is understood that other configurations of the subject technology will become readily apparent to those skilled in the art from the following detailed description, wherein various configurations of the subject technology are shown and described by way of illustration. As will be realized, the subject technology is capable of other and different configurations and its several details are capable of modification in various other respects, all without departing from the scope of the subject technology. Accordingly, the drawings and detailed description are to be regarded as illustrative in nature and not as restrictive.
Certain features of the subject technology are set forth in the appended claims. However, for purpose of explanation, several embodiments of the subject technology are set forth in the following figures.
The detailed description set forth below is intended as a description of various configurations of the subject technology and is not intended to represent the only configurations in which the subject technology may be practiced. The appended drawings are incorporated herein and constitute a part of the detailed description. The detailed description includes specific details for the purpose of providing a thorough understanding of the subject technology. However, it will be clear and apparent to those skilled in the art that the subject technology is not limited to the specific details set forth herein and may be practiced using one or more embodiments. In one or more instances, well-known structures and components are shown in block diagram form in order to avoid obscuring the concepts of the subject technology.
The network environment 100 includes network 105, a control system 110, one or more healthcare systems 120A-D, one or more healthcare devices 130A-F, and one or more user devices 140A-C. The control system 110, healthcare systems 120A-D, healthcare devices 130A-F, and/or user devices 140A-C may be communicatively coupled to one another, such as by the network 105. In one or more embodiments, one or more of the control system 110, healthcare systems 120A-D, healthcare devices 130A-F, or user devices 140A-C may be directly coupled to one another. In addition, there may be a number of other devices connected to the network 105, such as additional healthcare systems, e.g. other clinical and/or logistical systems, additional healthcare devices, external systems, computing devices, mobile devices, etc. The control system 110, one or more healthcare systems 120A-D, one or more healthcare devices 130A-F, and/or one or more user devices 140A-C may be, or may include all or part of, the electronic system that is discussed further below with respect to
The network 105 may be a communication network, such as a public communication network (such as the Internet, cellular data network, dialup modems over a telephone network), a private communications network (such as private local area network (“LAN”), leased lines), etc. The network 105 may also include, but is not limited to, any one or more of the following network topologies, including a bus network, a star network, a ring network, a mesh network, a star-bus network, a tree or hierarchical network, and the like. The connections of the network 105 may be wired or wireless. For example, one or more of the control system 110, healthcare systems 120A-D, healthcare devices 130A-F, and/or user devices 140A-C may transmit wireless signals over the network 105, such as radio frequency (RF) signals, infrared (IR) signals, Bluetooth signals, or any other means capable of carrying information in a wireless manner between devices having appropriate transmitters and/or receivers.
The control system 110 may be a single computing device such as a computer server. Alternatively, the control system 110 may represent one or more computing devices (such as a cloud of computers and/or a distributed system) that are communicatively coupled, such as communicatively coupled over the network 105, and that collectively, or individually, perform one or more functions that can be performed server-side, such as receiving messages, transmitting messages, storing messaging, receiving control commands, providing user interfaces, transmitting notifications, etc. The one or more computing devices of the control system 110 may be geographically collocated and/or the one or more computing devices of the control system 110 may be disparately located. The control system 110 may be coupled with various databases, such as data store 114, storage services, or other computing devices. The control system 110, and the coupled databases, storage services, or other computing devices may be geographically collocated, or may be disparately located. In one or more embodiments, the control system 110 includes a processing device 112 and a data store 114. The processing device 112 executes computer instructions stored in the data store 114. In one or more embodiments, the data store 114 may store the computer instructions on non-transitory computer-readable medium.
The one or more healthcare systems 120A-D may be any systems that facilitate with providing healthcare, and/or provide healthcare. In
The PIS may store, for example, information pertaining to a pharmacy of a healthcare facility, such as outstanding orders, filled orders, patient medical profiles/histories, etc. For example, the PIS may provide a library of drug allergies and adverse drug interactions against which each incoming order, or prescription, is checked as part of the order entering/drug dispensing process to identify possible allergies and adverse drug interactions and help in preventing administration of drugs to a patient where the patient might be injured by the prescribed course of therapy. Additionally, the PIS may check to determine if any therapies are being duplicated, such as where two or more drugs might be used to treat a diagnosed disease, whether they are synergistic or antagonistic, and whether the prescribed therapy should be modified accordingly. The LIS may store laboratory results, such as for tests performed to facilitate with providing healthcare to patients.
The healthcare devices 130A-F may include infusion devices, such as infusion pumps, drug delivery devices, dispensing devices, such as automated dispensing machines, smart beds, monitoring devices, respiratory devices, such as ventilators, waste devices, such as drug disposal devices, or generally any device that may facilitate with providing healthcare and/or may provide healthcare. The healthcare devices 130A-F may include a processor and memory. Alternatively, or in addition, the healthcare devices 130A-F may be communicatively coupled to a device that includes a processor and a memory, such as via a serial port.
For example, the healthcare devices 130A-F may include Pyxis Medstations™ to store and dispense medications at the nurses stations, providing distributed access to the medications needed to treat patients, Pyxis® Anesthesia Systems to store and manage the medications used by anesthesiologists in the operating room, Pyxis SpecialtyStations™ to store specific medications and supplies in individual treatment areas, and Pyxis OncologyStations™ in oncology departments to manage the specialized and hazardous medications used to treat cancer. The healthcare devices 130A-F may also include waste devices that accept and store wasted medications, e.g. excess medications, from healthcare professionals and track the amount of medications wasted by healthcare professionals. In one or more embodiments, one or more of the waste devices may be a Pyxis EcoStation™ system.
The user devices 140A-C may be electronic devices such as laptop or desktop computers, mobile phones, personal digital assistants (“PDAs”), portable media players, tablet computers, televisions or other displays, or other appropriate computing devices that can be used to display user interfaces that facilitate providing healthcare to patients, such as user interfaces that display information related to providing healthcare to patients and/or user interfaces that allow a healthcare professional, such as a doctor or nurse, access, create, and/or modify information related to providing healthcare to patients, such as modifying a schedule for preparing IVs in the PIS. Example user interfaces are discussed further below with respect to
In one or more embodiments, the user devices 140A-C may be, may include, and/or may be communicatively coupled to, a Medical Transaction Carrier (MTC). The user devices 140A-C, and/or the MTCs included therein and/or communicatively coupled thereto, may be configured to initiate communication with the control system 110, and/or any of the healthcare devices 130A-F, when the user devices 140A-C are located within a proximity, e.g. a predetermined distance, of any of the healthcare devices 130A-F, and/or within a proximity of one or more patients. Alternatively, or in addition, the control system 110, and/or any of the healthcare devices 130A-F, may be configured to initiate communication with the user devices 140A-C, and/or the MTCs included therein and/or communicatively coupled thereto, when the user devices 140A-C are located within a proximity, e.g. a predetermined distance, of any of the healthcare devices 130A-F, and/or within a proximity of one or more patients.
In one or more embodiments, the user devices 140A-C, and/or the MTCs included therein and/or communicatively coupled thereto, may be configured to initiate communication with any of the healthcare systems 120A-D when the user devices 140A-C are located within a proximity, e.g. a predetermined distance, of any of the healthcare devices 130A-F, and/or within a proximity of one or more patients. Alternatively, or in addition, any of the healthcare systems 120A-D may be configured to initiate communication with the user devices 140A-C, and/or the MTCs included therein and/or communicatively coupled thereto, when the user devices 140A-C are located within a proximity, e.g. a predetermined distance, of any of the healthcare devices 130A-F, and/or within a proximity of one or more patients.
In operation, the control system 110, the healthcare systems 120A-D, the healthcare devices 130A-F, and/or the user devices 140A-C may transmit electronic data streams to one another over the network 105. The messages may relate to healthcare that is being facilitated by any of the healthcare systems 120A-D, the healthcare devices 130A-F, and/or the user devices 140A-C. For example, a message may include an order for a medication that is transmitted from a POE system to a PIS. In one or more embodiments, at least a portion of the message may later be transmitted by the PIS to a healthcare device 130A, such as to indicate that the ordered medication should be administered to the patient. Alternatively, or in addition, a message may relate to the progress of the delivery of medication, such as by one or more of the healthcare devices 130A-F. For example, the healthcare device 130A may transmit a message to the PIS that indicates the progress of delivering the medication by the healthcare device 130A to the patient. For example, the message may indicate that the healthcare device 130A has started delivering the medication, the healthcare device 130A has delivered an indicated amount of the medication, or the healthcare device 130A has completed the delivery of the medication.
The control system 110 may provide user identity and notification systems. For example, the control system 110 may authenticate users and may control the access of a user, or a group of users. For example, a physician may be allowed to input orders into a POE system, while a nurse may only be allowed to view the orders in the POE system. Thus, the control system 110 may provide different views of information, e.g. information received from one or more of the healthcare systems 120A-D and/or the healthcare devices 130A-F, to different users based on the users' access privileges. The control system 110 may also provide user interfaces to users, such as via the user devices 140A-C, and may manage the users' interactions with the user interfaces. In one or more embodiments, the control system 110 may provide information for a patient to a user device 140A to be displayed on one of the user interfaces when the control system 110 determines that the user device 140A is within a proximity of the patient and/or within a proximity of one of the healthcare devices 130A-F that is providing, and/or facilitating with providing, healthcare to the patient. An example process of a context-aware notification system is discussed further below with respect to
Alternatively, or in addition, the user device 140A may determine that it is located within a proximity of a patient and/or within a proximity of one of the healthcare devices 130A-F. The user device 140A may then transmit an indication to the control system 110 indicating that the user device 140A is located within the proximity of the patient and/or the one of the healthcare devices 130A-F. In response thereto, the control system 110 may transmit information to the user device 140A that pertains to the patient and/or the one of the healthcare devices 130A-F. Example processes for one or more of the user devices 140A-C in a context-aware notification system are discussed further below with respect to
The control system 110 may also transmit notifications to one or more of the users, such as via the user devices 140A-C. For example, the control system 110 may transmit a notification to a user device 140A being accessed by a user, e.g. a user device 140A that the user has authenticated on, when the control system 110 determines that the user is within proximity of a patient who may need care, e.g. a patient that is receiving healthcare from one of the healthcare devices 130A-F that may be experiencing an error. In one or more embodiments, one or more of the notifications may be transmitted to the user devices 140A-C via a user interface. For example, the notification may cause a graphical indicator to be presented on a user interface being displayed on a user device 140A. Example user interfaces for presenting notifications are discussed further below with respect to
The messaging architecture 200 includes the control system 110, one or more healthcare systems 120A-D, one or more healthcare devices 130A-F, and one or more user devices 140A-C. The control system 110, healthcare systems 120A-D, healthcare devices 130A-F, and user devices 140A-C may be communicably coupled to one another, such as by the network 105 shown in
In one or more embodiments, messages transmitted by the healthcare systems 120A-D, the healthcare devices 130A-F, and/or the user devices 140A-C may be routed through the control system 110, e.g. via the interfaces 210A-M. For example, if a healthcare device 130A is sending a message to the healthcare system 120C, the healthcare device 130A may utilize the interface 210A to transmit the message to the control system 110, and the control system 110 may forward the message to the interface 210H, which provides the message to the healthcare system 120C. In one or more embodiments, the control system 110 may store the messages, such as in the data store 114, for further processing, such as to identify whether to transmit any information indicated in the messages to one or more of the user devices 140A-C, such as via a notification and/or via a user interface.
In one or more embodiments, the control system 110 may include an interface system that receives the messages from one or more of the healthcare systems 120A-D, the healthcare devices 130A-F, and/or the user devices 140A-C, via the interfaces 210A-M. The interface system may provide the interfaces 210A-M to the one or more of the healthcare systems 120A-D, the healthcare devices 130A-F, and the user devices 140A-C, and the one or more of the healthcare systems 120A-D, the healthcare devices 130A-F, and the user devices 140A-C may transmit messages to the interface system by utilizing the interfaces 210A-M.
In one or more embodiments, the interface system receives the messages in a first external format, e.g. a format native to the transmitting device and/or system, converts the messages into an internal messaging format, e.g. for processing and storing the messages, converts the messages into a second external format, e.g. a format native to the receiving device and/or system, and then transmits the messages in the second external format to the receiving device. In one or more embodiments, the first external format may be the same as the second external format. The interface system may be implemented as described, for example, in U.S. patent application Ser. No. 13/421,776, entitled “Scalable Communication System,” filed on Mar. 15, 2012, which has been incorporated by reference in its entirety for all purposes.
Alternatively, or in addition, one or more of the healthcare systems 120A-D, the healthcare devices 130A-F, and/or the user devices 140A-C may communicate with the control system 110 without utilizing the interfaces 210A-M. Alternatively, or in addition, one or more of the healthcare systems 120A-D, the healthcare devices 130A-F, and/or the user devices 140A-C may transmit messages directly to one another, e.g. without routing the messages through the control system 110.
The messaging architecture 300 includes an interface system 320, the control system 110, one or more healthcare systems 120A-D, one or more healthcare devices 130A-F, and one or more user devices 140A-C. The control system 110, interface system 320, healthcare systems 120A-D, healthcare devices 130A-F, and user devices 140A-C may be communicably coupled to one another, such as by the network 105 shown in
In the messaging architecture 300, the interface system 320 may be separate from the control system 110, e.g. such that messages to/from the control system 110 are routed through the interface system 320. For example, the control system 110 and the interface system 320 may be separate devices, such as separate servers, or the control system 110 and the interface system 320 may be and/or may include distinct hardware on the same device. Alternatively, the control system 110 may receive messages directly from the interface system 320, e.g. without the use of the interface 310. Thus, in the messaging architecture 300, messages are routed through the interface system 320, rather than through the control system 110, as previously discussed with respect to
Alternatively, or in addition, one or more of the healthcare systems 120A-D, the healthcare devices 130A-F, the user devices 140A-C, and/or the control system 110 may communicate with the interface system 320 without utilizing the interfaces 210A-M, 310. Alternatively, or in addition, one or more of the healthcare systems 120A-D, the healthcare devices 130A-F, the user devices 140A-C, and/or the control system 110 may transmit messages directly to one another, e.g. without routing the messages through the interface system 320.
In block 402, the control system 110 determines that one of the user devices 140A-C, such as the user device 140A, is located within a proximity of one of the healthcare devices 130A-F, such as the healthcare device 130A, and/or within a proximity of a patient, such as a patient for whom healthcare is being provided by, and/or facilitated by, one of the healthcare devices 130A-F, such as the healthcare device 130A. In one or more embodiments, the control system 110 may receive an indication from the user device 140A, and/or one or more of the healthcare devices 130A-F, indicating that the user device 140A is located within a proximity of one of the healthcare devices 130A-F and/or one or more patients. For example, the healthcare device 130A may be configured to determine when one of the user devices 140A-C is located within a proximity of the healthcare device 130A, e.g. by detecting one or more wireless signals transmitted by the user devices 140A-C, such as Infrared signals, wireless Ethernet signals, Bluetooth signals, or generally any wireless signals that are transmissible by the user devices 140A-C. Alternatively, or in addition, the healthcare device 130A may include an induction coil, and the healthcare device 130A may be configured to utilize the induction coil to determine whether the healthcare device 130A can interface with any of the user devices 140A-C.
Alternatively, or in addition, the control system 110 may determine that the user device 140A is located within a proximity of the healthcare device 130A based at least in part on information and/or signals that are received, directly or indirectly, from the user device 140A and/or the healthcare device 130A. For example, the control system 110 may utilize triangulation or other positioning techniques to determine the locations of the user device 140A and/or the healthcare device 130A based on wireless signals received from the user device 140A and/or the healthcare device 130A. Alternatively, or in addition, the control system 110 may receive information from one or more of the healthcare systems 120A-D that indicates the location of the healthcare device 130A, such as over the network 105. The control system 110 may then determine the location of the user device 140A and/or whether the user device 140A is located within a proximity of the location of the healthcare device 130A.
In one or more embodiments, the healthcare device 130A may store an identifier of a patient for whom the healthcare device 130A is providing healthcare, and/or facilitating with providing healthcare. Thus, the healthcare device 130A may provide the control system 110 with an identifier of a patient that may be located within a proximity of the user device 140A, e.g. when the healthcare device 130A is located within the proximity of the user device 140A. Alternatively, or in addition, the control system 110 may retrieve an identifier of the patient for whom the healthcare device 130A is providing, and/or facilitating with providing, healthcare from one or more of the healthcare systems 140A-D.
In one or more embodiments, the patients may be provided with a patient information device, such as a wristband, necklace, ankle band, etc., that may be, or may include, an active embedded computer and/or a passive device, such as a radio frequency identification device. The patient information device may be responsive to devices located throughout the healthcare facility, such as readers or wireless transmitter/receivers, to provide the identity of the patient associated with the patient information device, and/or other information, when the patient information device is queried, e.g. activated, by the devices. In one or more embodiments, any of the healthcare devices 130A-F, and/or any of the user devices 140A-C, may include the devices that query, e.g. activate, the patient information device and receive the patient identifiers from the patient information devices.
Thus, in one or more embodiments, the devices that are located throughout the hospital may receive identifiers of proximally located patients, e.g. patients that are located within a proximity of the devices, and the devices may transmit the identifiers of the patients to the control system 110, such as over the network 105. The control system 110 may retrieve the locations of the devices from one or more of the healthcare systems 120A-D, such as a hospital information system, and the control system 110 may determine the approximate locations of the patients based on the location of the devices that transmitted the identifiers of the patients. The control system 110 may then determine whether any of the user devices 140A-C are located within a proximity of the approximate locations of any of the patients.
In block 404, the control system 110 may receive information from one or more of the healthcare systems 120A-D that is related to the healthcare device 130A that is located within a proximity of the user device 140A, and/or that is related to any patients that are located within a proximity of the user device 140A. For example, the control system 110 may receive information from one or more of the healthcare systems 120A-D over the network 105. In one or more embodiments, the received information may include information regarding medications being provided to a patient, such as from the pharmacy information system, lab results for a patient, such as from a laboratory information system, a medical history and/or profile of the patient, such as from the pharmacy information system and/or a hospital information system, the status of medications being prepared for the patient, such as from a pharmacy information system, maintenance and/or calibration information related to the healthcare device 130A, and/or generally any information that may be provided by any of the healthcare systems 120A-D. In one or more embodiments, the control system 110 may not receive any information from any of the healthcare systems 120A-D, e.g. the control system 110 may, in one or more embodiments, skip block 404.
In block 406, the control system 110 may receive information from the healthcare device 130A that is located within a proximity of the user device 140A. The received information may be related to the healthcare device 130A, and/or the received information may be related to any patients that are located within a proximity of the user device 140A. For example, the control system 110 may receive information from the healthcare device 130A over the network 105. In one or more embodiments, the information may include information related to the progress of delivering a medication to a patient, such as from an infusion pump, information related to the monitoring of a vital sign of a patient, such as from a monitoring device, information related to the progress of a respiratory protocol being implemented for the patient, such as from a respiratory device, or generally any information that may be received from the healthcare device 130A. In one or more embodiments, the control system 110 may not receive any information from the healthcare device 130A, e.g. the control system 110 may, in one or more embodiments, skip block 406.
In block 408, the control system 110 transmits at least a portion of the information received from one or more of the healthcare systems 120A-D, and/or the healthcare device 130A, to the user device 140A. For example, the control system 110 may transmit at least a portion of the received information to the user device 140A over the network 105. In one or more embodiments, the user device 140A may display the at least the portion information, e.g. to a healthcare professional, such as a physician or a nurse, as is discussed further below with respect to
Alternatively, or in addition, the control system 110 may process the information received from the one or more healthcare systems 120A-D, and/or the healthcare device 130A, such as to generate workflow information, control information, or other information that can be generated from processing the received information. The control system 110 may then transmit the processed information, and/or the information generated at least in part from processing the received information, to the user device 140A. For example, the control system 110 may process the received information to determine whether any corrective actions are required, any safety issues exists, and/or any errors exists. If the control system 110 determines that any corrective actions are required, any safety issues exists, and/or any errors exists, the control system 110 may transmit an indication of the corrective action, the safety issue, and/or the error to the user device 140A, such as via an alert and/or notification.
In one or more embodiments, the control system 110 may process the information received from the one or more healthcare systems 120A-D, and/or the healthcare device 130A, in addition to information received from the user device 140A, in order to provide context to an alert and/or notification. The control system 110 may utilize information such as the proximity of the user device 140A to the healthcare device 130A, a condition of a patient whom the healthcare device 130A is providing healthcare, a type of medication being administered to the patient, or generally any other received information, to provide context to an alert and/or notification. For example, if the processed information indicates that a healthcare professional is standing next to the healthcare device 130A, then the control system 110 may cause a visual alert to be displayed to the healthcare professional, rather than an audible alert. Similarly, if the processed information indicates, e.g., that medication on an infusion pump is not life critical, then the control system 110 may provide a notification to a healthcare professional who is caring for the patient but is located remotely from the infusion pump, rather than any healthcare professional who is located proximally to the infusion pump.
Alternatively, or in addition, the control system 110 may delay alarms on the healthcare devices 130A-F, and/or may allow a healthcare professional to indicate that they will respond to an alarm within a configurable amount of time. For example, if a healthcare professional indicates that they will respond to an alarm of a healthcare device 130A within a configurable amount of time, the control system 110 may cause the healthcare device 130A to not generate the alarm unless the configurable amount of time has elapsed and the healthcare professional has not responded to the alarm.
In one or more embodiments, a healthcare professional may remotely determine, such as via one of the user devices 140A-C, that an action should be taken by a pump, such as restarting the pump when the volume counts down to zero, and adding a small amount of volume to allow the infusion to restart and to provide an associated nurse with a more convenient time to address the infusion, e.g. to change to a new bag. Thus, a healthcare professional may be able to address an alarm of a healthcare device 130A remotely, such as via one of the user devices 140A-C. Alternatively, or in addition, the control system 110, and/or a drug library, may store actions that may be taken remotely, e.g. via one of the user devices 140A-C, based on characteristics of the healthcare device 130A, the patient, the alarm, etc. For example, the control system 110 may allow different actions to be performed remotely, via reprogramming a healthcare device 130A, based on one or more of: the type of drug being administered by the healthcare device 130A, the type of alarm being generated by the healthcare device 130A, the patient care area where the healthcare device 130A is located, and/or generally any characteristics associated with the healthcare device 130A and/or the patient.
In block 502, a user device 140A determines that it is located within a proximity of a healthcare device and/or a patient. For example, the user device 140A may include a device that is configured to query patient information devices that, for example, may be worn by patients. Thus, the user device 140A may determine that it is located within a proximity of a patient when the user device 140A receives a response from a queried patient information device of a patient. In one or more embodiments, the user device 140A may determine that it is located within a proximity of a healthcare device 130A based on wireless signals received from the healthcare device 130A, and/or a device or wireless interface coupled thereto. The wireless signals may include, e.g., Infrared signals, Bluetooth signals, wireless Ethernet signals, and/or generally any wireless signals. For example, the user device 140A may measure the strength of a signal received from the healthcare device 130A, such as for a wireless Ethernet signal and/or other long range wireless signals, and/or the user device 140A may determine whether it receives any signal from the healthcare device 130A, such as for Infrared signals, Bluetooth signals, and/or other short range wireless signals. In one or more embodiments, the user device 140A may include an induction coil that may be utilized by the user device 140A to determine whether the user device 140A can interface with the healthcare device 130A, such as via radio frequency identification. The user device 140A may transmit an indication to the control system 110, the interface system 320, and/or any of the healthcare systems 120A-D, when the user device 140A determines that it is located within a proximity of the healthcare device 130A.
Alternatively, or in addition, the user device 140A may receive an indication from the control system 110, the healthcare device 130A, the interface system 320, and/or any of the healthcare systems 120A-D, that indicates that the user device 140A is located within a proximity of the healthcare device 130A and/or one or more patients. In this instance, the user device 140A may determine that it is located within a proximity of the healthcare device 130A and/or the one or more patients based at least in part on the received indication.
In block 504, the user device 140A receives information that relates to the proximally located healthcare device 130A and/or the one or more proximally located patients. For example, the user device 140A may receive the information from the control system 110, such as over the network 105. Alternatively, or in addition, the user device 140A may receive the information from one or more of the healthcare systems 120A-D and/or the interface system 320, such as over the network 105.
In block 506, the user device 140A determines whether the received information indicates that corrective action is required, a safety issue exists, or an error exists with respect to the healthcare device 130A and/or the one or more proximally located patients. In one or more embodiments, the control system 110 may determine that corrective action is required, a safety issue exists, and/or an error exists, and the received information may indicate the corrective action, safety issue and/or error determined by the control system 110, such as a safety issue or error with respect to delivery protocols, drug interactions, etc.
If, in block 506, the user device 140A determines that corrective action is required, a safety issue exists, and/or an error exists, the user device 140A moves to block 508. In block 508, the user device 140A displays an alert, or notification, that indicates the required corrective action, safety issue, and/or error. For example, the user device 140A may display a graphical indicator to indicate the existence of a required corrective action, a safety issue, or an error, with respect to the healthcare device 130A and/or the one or more proximally located patients, such as the asterisk (“*”) indicator discussed below with respect to
If, in block 506, the user device 140A determines that the received information does not indicate that a corrective action is required, a safety issue exists, and/or an error exists, the user device 140A moves to block 510. In block 510, the user device 140A displays at least a portion of the received information. For example, the user device 140A may display at least a portion of the received information via one or more of the user interfaces that are discussed further below with respect to
Alternatively, or in addition, the user device 140A may not display the at least the portion of the received information until prompted by a user, such as a healthcare professional interacting with the user device 140A. For example, the user device 140A may display a notification to the healthcare professional that indicates that the received information is available, and that requests whether the healthcare professional would like the user device 140A to display the at least the portion of the received information on a screen of the user device 140A, and/or on a display or monitor proximally located to the user device 140A.
In block 602, the user device 140A receives an indication that it is located within a proximity of a healthcare device 130A and/or of one or more patients. For example, the user device 140A may receive the indication from the control system 110, the healthcare device 130A, the interface system 320, and/or any of the healthcare systems 120A-D, such as over the network 105. In one or more embodiments, the indication may be a wireless signal generated by the healthcare device 130A, and/or a device that is communicatively coupled thereto, that is detected by the user device 140A, such as an Infrared signal, a Bluetooth signal, a radio frequency identification signal, or generally any wireless signal.
In block 604, the user device 140A receives information that relates to the healthcare device 130A and/or the one or more proximally located patients. As previously discussed, the user device 140A may, e.g., receive the information from one or more of the control system 110, the healthcare systems 120A-D, and/or the interface system 320, such as over the network 105.
In block 606, the user device 140A may display at least a portion of the received information, such as via one or more of the user interfaces that are discussed below with respect to
The user interface 700 may display information relating to in-progress actions being performed by one or more of the healthcare devices 130A-F, such as medical orders being administered. For example, the user interface 700 displays a report of IVs that are being administered by, and/or with the facilitation of, one or more of the healthcare devices 130A-F. In one or more embodiments, the administrations of medical orders that will terminate within a preselected time period may be distinguished on the user interface 700 from other administrations by color highlighting or other means. The user interface 700 may further display the time remaining, medication, and patient name, as well as buttons for program control. In one or more embodiments, the user interface 700 may display pending infusions or infusions scheduled to begin within a preselected time period.
In operation, the user interface 700 may be provided by the control system 110, and/or one or more of the healthcare systems 120A-D, for display on a screen, such as a screen of one or more of the user devices 140A-C, and/or a screen or monitor associated with one or more of the healthcare systems 120A-D. For example, the control system 110 may receive messages from one or more of the healthcare devices 130A-F related to actions being performed by the one or more healthcare devices 130A-F. The control system 110 may parse the received messages to obtain the information displayed on the user interface 700, and/or the received messages may be displayed on the user interface 700.
The information displayed on the user interface 700 may be updated in real-time as the control system 110 and/or one or more of the healthcare systems 120A-D receives messages from the healthcare devices 130A-F, such as while orders are being administered to patients. In one or more embodiments, the user interface 700 may be used to modify the preparation of medications, such as by scheduling and/or rescheduling, the preparation of medications.
In one or more embodiments, the user interface 700 may also display notifications, and/or alerts, such as when a healthcare professional is associated with a user device 140A that is displaying the user interface 700. For example, in the user interface 700, the notifications may be indicated by an asterisk (“*”). In one or more embodiments, the healthcare professional may select information that is displayed with an asterisk, such as by touching or clicking on the information, to receive additional information regarding the notification. In one or more embodiments, one or more of the alerts and/or notifications may only be displayed when the healthcare professional is proximally located to the one or more healthcare devices 130A-F to which the alerts and/or notifications pertain.
The user interface 800 may display information relating to a patient, such as information received from one or more of the healthcare systems 120A-C and/or one or more of the healthcare devices 130A-F. The displayed information may include information related to medications and/or infusions, such as IVs, that are scheduled for the patient, and the information may be received from the healthcare system 120C. The information may further include information related to medications and/or infusions that are being administered to the patient, and this information may be received from one or more of the healthcare devices 130A-F. For example, the user interface 800 displays information related to scheduled medications and IVs for an identified patient. In one or more embodiments, the user interface 800 may be color coded to indicate the status and schedule of each medication administration. For example, a medication delivery window extending from thirty minutes prior and thirty minutes after the scheduled administration time may be indicated by a yellow band on the user interface 800.
In operation, the user interface 800 may be provided by the control system 110, and/or one or more of the healthcare systems 120A-D, for display on a screen, such as a screen of one or more of the user devices 140A-C, and/or a screen or monitor associated with one or more of the healthcare systems 120A-D. For example, the control system 110 may receive messages from one or more of the healthcare systems 120A-D, and/or one or more of the healthcare devices 130A-F, that relate to a patient. The control system 110 may parse the received messages to obtain the information displayed on the user interface 800, and/or the received messages may be displayed on the user interface 800.
In one or more embodiments, the user interface 800 may automatically be provided to the user device 140A of a healthcare professional when the healthcare professional is located within a proximity of the patient and/or within a proximity of one or more healthcare devices 130A-F that are providing, and/or facilitating with providing, healthcare to the patient. Thus, the user device 140A of a healthcare professional may automatically display, and/or prepare for display, information related to an identified patient when the healthcare professional is within proximity of the patient, such as at the bedside of the patient. Accordingly, the information displayed on the user interface 800 may change as the healthcare professional moves throughout the healthcare facility.
In one or more embodiments, the user device 140A may receive information for displaying the user interface 800 when the healthcare professional is proximally located to the patient, but the user device 140A may not display the user interface 800 until prompted by the healthcare professional. For example, the user device 140A may receive the information for displaying the user interface 800 and may then display a notification to the healthcare professional indicating that the information is available, and requesting whether the healthcare professional would like the user interface 800 to be displayed on the user device 140A and/or on a display or monitor proximally located to the user device 140A.
The information displayed on the user interface 800 may be updated in real-time as the control system 110 and/or one or more of the healthcare systems 120A-D receives messages from the healthcare devices 130A-F, such as while orders are being administered to the patient. In one or more embodiments, the user interface 800 may be used to schedule and/or reschedule, the preparation of medications, such as by the healthcare system 120C.
The information displayed on the user interface 800 may be updated in real-time as the control system 110 and/or one or more of the healthcare systems 120A-D receives messages from the healthcare devices 130A-F and/or the healthcare systems 120A-D, such as while orders are being administered to patients, while orders are being prepared for administration to patients, and/or when orders are received from a physician order entry system. In one or more embodiments, the user interface 800 may be used to verify the administration of orders, such as a healthcare professional verifying that a medication scheduled for administration and/or a medication being administered coincides with the ordered medication. In one or more embodiments, a healthcare professional may be able to select, such as touch or click on, an order and the user interface 800 may display a picture of the medication being administered, or about to be administered.
The user interface 900 may display information to an identified healthcare professional that relates to in-progress actions being performed by, and/or with the facilitation of, one or more of the healthcare devices 130A-F, and for which the healthcare professional is facilitating and/or monitoring. The user interface 900 may also display information to the identified healthcare professional that relates to future actions to be performed by, and/or with the facilitation of, one or more of the healthcare devices 130A-F, and for which the healthcare professional is facilitating and/or monitoring. Alternatively, or in addition, the user interface 900 may display information related to in-progress or future actions that are being performed proximally to the user device 140A, and a healthcare professional accessing the user device 140A. For example, the user interface 900 displays a report of IVs that are being administered by one or more of the healthcare devices 130A-F. In one or more embodiments, the user interface 900 may include scheduling of medication administrations to ensure proper medication of the patient while distributing the workload over a period of time to ensure that all medication is given promptly.
In operation, the user interface 900 may be provided by the control system 110, and/or one or more of the healthcare systems 120A-D, for display on a screen, such as a screen of one or more of a user devices 140A being accessed by a healthcare professional, and/or a screen or monitor associated with one or more of the healthcare systems 120A-D. For example, the control system 110 may receive messages from one or more of the healthcare systems 120A-D, and/or one or more of the healthcare devices 130A-F, that relate to in-progress actions and/or future actions that are being performed with the facilitation of the healthcare professional, and/or that are being performed proximally to the healthcare professional, as indicated by the location of the user device 140A. The control system 110 may parse the received messages to obtain the information displayed on the user interface 900, and/or the received messages may be displayed on the user interface 900.
In one or more embodiments, the user interface 900 may automatically be provided to the user device 140A of a healthcare professional when the healthcare professional is located within a proximity of the patient and/or within a proximity of one or more healthcare devices 130A-F that are providing, and/or facilitating with providing, healthcare to one or more patients. Thus, the user device 140A of a healthcare professional may automatically display, and/or prepare for display, information related to in-progress and/or future actions that are being performed, and/or will be performed, proximally to the location of the healthcare professional. Accordingly, the information displayed on the user interface 900 may change as the healthcare professional moves throughout the healthcare facility.
In one or more embodiments, the user device 140A may receive information for displaying the user interface 900 when the healthcare professional is proximally located to in-progress, or future actions, but the user device 140A may not display the user interface 900 until prompted by the healthcare professional. For example, the user device 140A may receive the information for displaying the user interface 900 and may then display a notification to the healthcare professional indicating that the information is available, and requesting whether the healthcare professional would like the user interface 900 to be displayed on the user device 140A and/or on a display or monitor proximally located to the user device 140A.
The information displayed on the user interface 900 may be updated in real-time as the control system 110 and/or one or more of the healthcare systems 120A-D receives messages from the healthcare devices 130A-F, such as while orders are being administered to patients. In one or more embodiments, the user interface 900 may be used to verify the administration of orders, such as a healthcare professional verifying that a medication scheduled for administration and/or a medication being administered coincides with the ordered medication. In one or more embodiments, a healthcare professional may be able to select, such as touch or click on, an order and the user interface 900 may display a picture of the medication being administered, or about to be administered.
The user interface 1000 may display information relating to patients in a healthcare facility and/or in an area of a healthcare facility, such as alerts or notifications related to healthcare being administered to patients in a healthcare facility. For example, the user interface 1000 may display a graphical representation of each room in an area of the healthcare facility, the name of the patient occupying each room, if any, and any alerts or notifications that apply to any of the displayed patients. In the user interface 1000, an alert or notification is indicated by an asterisk (“*”); however, any other graphical indicator may be used to indicate an alert and/or notification.
In operation, the user interface 1000 may be provided by the control system 110, and/or one or more of the healthcare systems 120A-D, for display on a screen, such as a screen of one or more of the user devices 140A-C, and/or a screen or monitor associated with one or more of the healthcare systems 120A-D. For example, the control system 110 may receive messages from one or more of the healthcare devices 130A-F related to actions being performed by the or more healthcare devices 130A-F. The control system 110 may parse the received messages to determine whether any alerts and/or notifications should be displayed via the user interface 1000, such as whether any discrepancies and/or errors are identified from the received messages.
In one or more embodiments, the user interface 1000 may automatically be provided to the user device 140A of a healthcare professional when the healthcare professional is located within a proximity of the area of the healthcare facility represented on the user interface 1000. Thus, the user device 140A of a healthcare professional may automatically display, and/or prepare for display, the user interface 1000 when a healthcare professional is proximally located to the represented area. Accordingly, the information displayed on the user interface 1000 may change as the healthcare professional moves throughout the healthcare facility.
In one or more embodiments, the user device 140A may receive information for displaying the user interface 1000 when the healthcare professional is located proximally to the represented area, but the user device 140A may not display the user interface 1000 until prompted by the healthcare professional. For example, the user device 140A may receive the information for displaying the user interface 1000 and may then display a notification to the healthcare professional indicating that the information is available, and requesting whether the healthcare professional would like the user interface 1000 to be displayed on the user device 140A and/or on a display or monitor proximally located to the user device 140A.
The information displayed on the user interface 1000 may be updated in real-time as the control system 110 and/or one or more of the healthcare systems 120A-D receives messages from the healthcare devices 130A-F, such as while orders are being administered to patients.
In one or more embodiments, the user interface 1000 may display the status of each patient's infusion, and when an alert occurs, the box representing the patient's room flashes red to attract attention to the alert. Accordingly, a healthcare professional accessing the user interface 1000 may be able to quickly and easily identify the patient from the user interface, such as at a nursing station, and take appropriate action to address the condition causing the alert. In one or more embodiments, certain alerts that have been identified as particularly important events may be displayed on multiple screens throughout the healthcare facility, such as in the pharmacy.
In one or more embodiments, the user interface 1000 may also be used for updating administrative records of the healthcare facility. For example, if a patient changes rooms, a healthcare professional can transmit a notification of the room change to the control system 110 by selecting the patient's name, and dragging that patient to the new room. In addition, the user interface 1000 may be updated to reflect the room change.
Bus 1108 collectively represents all system, peripheral, and chipset buses that communicatively connect the numerous internal devices of electronic system 1100. In one or more embodiments, bus 1108 communicatively connects processing unit(s) 1112 with ROM 1110, system memory 1104, and permanent storage device 1102. From these various memory units, processing unit(s) 1112 retrieves instructions to execute and data to process in order to execute the processes of the subject disclosure. The processing unit(s) can be a single processor or a multi-core processor in different embodiments.
ROM 1110 stores static data and instructions that are needed by processing unit(s) 1112 and other modules of the electronic system. Permanent storage device 1102, on the other hand, is a read-and-write memory device. This device is a non-volatile memory unit that stores instructions and data even when electronic system 1100 is off. One or more embodiments of the subject disclosure use a mass-storage device (such as a magnetic or optical disk and its corresponding disk drive) as permanent storage device 1102.
Other embodiments use a removable storage device (such as a floppy disk, flash drive, and its corresponding disk drive) as permanent storage device 1102. Like permanent storage device 1102, system memory 1104 is a read-and-write memory device. However, unlike storage device 1102, system memory 1104 is a volatile read-and-write memory, such as random access memory. System memory 1104 stores any of the instructions and data that processing unit(s) 1112 needs at runtime. In one or more embodiments, the processes of the subject disclosure are stored in system memory 1104, permanent storage device 1102, and/or ROM 1110. From these various memory units, processing unit(s) 1112 retrieves instructions to execute and data to process in order to execute the processes of one or more embodiments.
Bus 1108 also connects to input and output device interfaces 1114 and 1106. Input device interface 1114 enables a user to communicate information and select commands to the electronic system. Input devices used with input device interface 1114 include, for example, alphanumeric keyboards and pointing devices (also called “cursor control devices”). Output device interface 1106 enables, for example, the display of images generated by electronic system 1100. Output devices used with output device interface 1106 include, for example, printers and display devices, such as a liquid crystal display (LCD), a light emitting diode (LED) display, an organic light emitting diode (OLED) display, a flexible display, a flat panel display, a solid state display, a projector, or any other device for outputting information.
One or more embodiments may include devices that function as both input and output devices, such as a touchscreen. In these embodiments, feedback provided to the user can be any form of sensory feedback, such as visual feedback, auditory feedback, or tactile feedback; and input from the user can be received in any form, including acoustic, speech, or tactile input.
Finally, as shown in
Many of the above-described features and applications may be implemented as software processes that are specified as a set of instructions recorded on a computer readable storage medium (alternatively referred to as computer-readable media, machine-readable media, or machine-readable storage media). When these instructions are executed by one or more processing unit(s) (e.g., one or more processors, cores of processors, or other processing units), they cause the processing unit(s) to perform the actions indicated in the instructions. Examples of computer readable media include, but are not limited to, RAM, ROM, read-only compact discs (CD-ROM), recordable compact discs (CD-R), rewritable compact discs (CD-RW), read-only digital versatile discs (e.g., DVD-ROM, dual-layer DVD-ROM), a variety of recordable/rewritable DVDs (e.g., DVD-RAM, DVD-RW, DVD+RW, etc.), flash memory (e.g., SD cards, mini-SD cards, micro-SD cards, etc.), magnetic and/or solid state hard drives, ultra density optical discs, any other optical or magnetic media, and floppy disks. In one or more embodiments, the computer readable media does not include carrier waves and electronic signals passing wirelessly or over wired connections, or any other ephemeral signals. For example, the computer readable media may be entirely restricted to tangible, physical objects that store information in a form that is readable by a computer. In one or more embodiments, the computer readable media is non-transitory computer readable media, computer readable storage media, or non-transitory computer readable storage media.
In one or more embodiments, a computer program product (also known as a program, software, software application, script, or code) can be written in any form of programming language, including compiled or interpreted languages, declarative or procedural languages, and it can be deployed in any form, including as a stand alone program or as a module, component, subroutine, object, or other unit suitable for use in a computing environment. A computer program may, but need not, correspond to a file in a file system. A program can be stored in a portion of a file that holds other programs or data (e.g., one or more scripts stored in a markup language document), in a single file dedicated to the program in question, or in multiple coordinated files (e.g., files that store one or more modules, sub programs, or portions of code). A computer program can be deployed to be executed on one computer or on multiple computers that are located at one site or distributed across multiple sites and interconnected by a communication network.
While the above discussion primarily refers to microprocessor or multi-core processors that execute software, one or more embodiments are performed by one or more integrated circuits, such as application specific integrated circuits (ASICs) or field programmable gate arrays (FPGAs). In one or more embodiments, such integrated circuits execute instructions that are stored on the circuit itself.
Those of skill in the art would appreciate that the various illustrative blocks, modules, elements, components, methods, and algorithms described herein may be implemented as electronic hardware, computer software, or combinations of both. To illustrate this interchangeability of hardware and software, various illustrative blocks, modules, elements, components, methods, and algorithms have been described above generally in terms of their functionality. Whether such functionality is implemented as hardware or software depends upon the particular application and design constraints imposed on the overall system. Skilled artisans may implement the described functionality in varying ways for each particular application. Various components and blocks may be arranged differently (e.g., arranged in a different order, or partitioned in a different way) all without departing from the scope of the subject technology.
It is understood that any specific order or hierarchy of blocks in the processes disclosed is an illustration of example approaches. Based upon design preferences, it is understood that the specific order or hierarchy of blocks in the processes may be rearranged, or that all illustrated blocks be performed. Any of the blocks may be performed simultaneously. In one or more embodiments, multitasking and parallel processing may be advantageous. Moreover, the separation of various system components in the embodiments described above should not be understood as requiring such separation in all embodiments, and it should be understood that the described program components and systems can generally be integrated together in a single software product or packaged into multiple software products.
As used herein, the phrase “at least one of” preceding a series of items, with the term “and” or “or” to separate any of the items, modifies the list as a whole, rather than each member of the list (i.e., each item). The phrase “at least one of” does not require selection of at least one of each item listed; rather, the phrase allows a meaning that includes at least one of any one of the items, and/or at least one of any combination of the items, and/or at least one of each of the items. By way of example, the phrases “at least one of A, B, and C” or “at least one of A, B, or C” each refer to only A, only B, or only C; any combination of A, B, and C; and/or at least one of each of A, B, and C.
The predicate words “configured to”, “operable to”, and “programmed to” do not imply any particular tangible or intangible modification of a subject, but, rather, are intended to be used interchangeably. In one or more embodiments, a processor configured to monitor and control an operation or a component may also mean the processor being programmed to monitor and control the operation or the processor being operable to monitor and control the operation. Likewise, a processor configured to execute code can be construed as a processor programmed to execute code or operable to execute code.
A phrase such as “an aspect” does not imply that such aspect is essential to the subject technology or that such aspect applies to all configurations of the subject technology. A disclosure relating to an aspect may apply to all configurations, or one or more configurations. An aspect may provide one or more examples of the disclosure. A phrase such as an “aspect” may refer to one or more aspects and vice versa. A phrase such as an “embodiment” does not imply that such embodiment is essential to the subject technology or that such embodiment applies to all configurations of the subject technology. A disclosure relating to an embodiment may apply to all embodiments, or one or more embodiments. An embodiment may provide one or more examples of the disclosure. A phrase such an “embodiment” may refer to one or more embodiments and vice versa. A phrase such as a “configuration” does not imply that such configuration is essential to the subject technology or that such configuration applies to all configurations of the subject technology. A disclosure relating to a configuration may apply to all configurations, or one or more configurations. A configuration may provide one or more examples of the disclosure. A phrase such as a “configuration” may refer to one or more configurations and vice versa.
The word “exemplary” is used herein to mean “serving as an example, instance, or illustration.” Any embodiment described herein as “exemplary” or as an “example” is not necessarily to be construed as preferred or advantageous over other embodiments. Furthermore, to the extent that the term “include,” “have,” or the like is used in the description or the claims, such term is intended to be inclusive in a manner similar to the term “comprise” as “comprise” is interpreted when employed as a transitional word in a claim.
All structural and functional equivalents to the elements of the various aspects described throughout this disclosure that are known or later come to be known to those of ordinary skill in the art are expressly incorporated herein by reference and are intended to be encompassed by the claims. Moreover, nothing disclosed herein is intended to be dedicated to the public regardless of whether such disclosure is explicitly recited in the claims. No claim element is to be construed under the provisions of 35 U.S.C. § 112, sixth paragraph, unless the element is expressly recited using the phrase “means for” or, in the case of a method claim, the element is recited using the phrase “step for.”
The previous description is provided to enable any person skilled in the art to practice the various aspects described herein. Various modifications to these aspects will be readily apparent to those skilled in the art, and the generic principles defined herein may be applied to other aspects. Thus, the claims are not intended to be limited to the aspects shown herein, but are to be accorded the full scope consistent with the language claims, wherein reference to an element in the singular is not intended to mean “one and only one” unless specifically so stated, but rather “one or more.” Unless specifically stated otherwise, the term “some” refers to one or more. Pronouns in the masculine (e.g., his) include the feminine and neuter gender (e.g., her and its) and vice versa. Headings and subheadings, if any, are used for convenience only and do not limit the subject disclosure.
The present application is a continuation of U.S. patent application Ser. No. 13/802,446, entitled “Context-Aware Healthcare Notification System,” filed on Mar. 13, 2013, now U.S. Pat. No. 11,087,873, which is a continuation-in-part of U.S. patent application Ser. No. 09/860,865, entitled “Distributed Remote Asset and Medication Management Drug Delivery System,” filed on May 18, 2001, now issued as U.S. Pat. No. 9,600,633, which claims priority to U.S. Provisional Patent Application Ser. No. 60/205,125, entitled “Distributed remote asset and medication management drug delivery system (DRAMMDDS),” filed on May 18, 2000, both of which are hereby incorporated by reference in their entirety for all purposes. U.S. patent application Ser. No. 13/802,446 is also a continuation-in-part of U.S. patent application Ser. No. 10/361,704, entitled “Medication Management and Event Logger and Analysis System,” filed on Feb. 9, 2003, which is hereby incorporated by reference in its entirety for all purposes. U.S. patent application Ser. No. 13/802,446 is also a continuation-in-part of U.S. patent application Ser. No. 10/750,032, entitled “Centralized Medication Management System,” filed on Dec. 31, 2003, which is hereby incorporated by reference in its entirety for all purposes. U.S. patent application Ser. No. 13/802,446 is also a continuation-in-part of U.S. patent application Ser. No. 13/246,782, entitled “System and Method for Dynamically Adjusting Patient Therapy,” filed on Sep. 27, 2011, which is a continuation of U.S. patent application Ser. No. 12/947,773, entitled “System and Method for Dynamically Adjusting Patient Therapy,” filed on Nov. 16, 2010, now issued as U.S. Pat. No. 8,340,792, which is a continuation of U.S. patent application Ser. No. 10/925,511, entitled “System and Method for Dynamically Adjusting Patient Therapy,” filed on Aug. 25, 2004, now issued as U.S. Pat. No. 7,860,583, all of which are hereby incorporated by reference in their entirety for all purposes. U.S. patent application Ser. No. 13/802,446 is also a continuation-in-part of U.S. patent application Ser. No. 11/326,145, entitled “Management of Pending Medication Orders,” filed on Dec. 30, 2005, now issued as U.S. Pat. No. 9,427,520, which claims priority to U.S. Provisional Patent Application Ser. No. 60/652,382, entitled “Management of Pending Medication Orders,” filed on Feb. 11, 2005, both of which are hereby incorporated by reference in their entirety for all purposes.
Number | Name | Date | Kind |
---|---|---|---|
2141006 | Marinsky | Dec 1938 | A |
3724455 | Unger | Apr 1973 | A |
3831006 | Chaffin, III et al. | Aug 1974 | A |
3848112 | Weichselbaum et al. | Nov 1974 | A |
3872448 | Mitchell, Jr. | Mar 1975 | A |
3898984 | Mandel et al. | Aug 1975 | A |
3910260 | Sarnoff et al. | Oct 1975 | A |
3921196 | Patterson | Nov 1975 | A |
3970996 | Yasaka et al. | Jul 1976 | A |
4051522 | Healy et al. | Sep 1977 | A |
4135241 | Stanis et al. | Jan 1979 | A |
4164320 | Irazoqui et al. | Aug 1979 | A |
4216462 | McGrath et al. | Aug 1980 | A |
4237344 | Moore | Dec 1980 | A |
4315309 | Coli | Feb 1982 | A |
4321461 | Walter, Jr. et al. | Mar 1982 | A |
4360125 | Martindale et al. | Nov 1982 | A |
4373527 | Fischell | Feb 1983 | A |
4476381 | Rubin | Oct 1984 | A |
4604847 | Moulding, Jr. et al. | Aug 1986 | A |
4636950 | Caswell et al. | Jan 1987 | A |
4674652 | Aten et al. | Jun 1987 | A |
4676776 | Howson | Jun 1987 | A |
4688026 | Scribner et al. | Aug 1987 | A |
4695954 | Rose et al. | Sep 1987 | A |
4696671 | Epstein et al. | Sep 1987 | A |
4731726 | Allen, III | Mar 1988 | A |
4733364 | Yamagata | Mar 1988 | A |
4741732 | Crankshaw et al. | May 1988 | A |
4756706 | Kerns et al. | Jul 1988 | A |
4778449 | Weber et al. | Oct 1988 | A |
4785969 | McLaughlin | Nov 1988 | A |
4803625 | Fu et al. | Feb 1989 | A |
4810243 | Howson | Mar 1989 | A |
4828545 | Epstein et al. | May 1989 | A |
4831562 | McIntosh et al. | May 1989 | A |
4835372 | Gombrich et al. | May 1989 | A |
4839806 | Goldfischer et al. | Jun 1989 | A |
4847764 | Halvorson | Jul 1989 | A |
4850009 | Zook et al. | Jul 1989 | A |
4853521 | Claeys et al. | Aug 1989 | A |
4855909 | Vincent et al. | Aug 1989 | A |
4857713 | Brown | Aug 1989 | A |
4857716 | Gombrich et al. | Aug 1989 | A |
4865584 | Epstein et al. | Sep 1989 | A |
4882575 | Kawahara | Nov 1989 | A |
4899839 | Dessertine et al. | Feb 1990 | A |
4916441 | Gombrich et al. | Apr 1990 | A |
4918604 | Baum | Apr 1990 | A |
4925444 | Orkin et al. | May 1990 | A |
4942544 | McIntosh et al. | Jul 1990 | A |
4950246 | Muller | Aug 1990 | A |
4967928 | Carter | Nov 1990 | A |
4970669 | McIntosh et al. | Nov 1990 | A |
4978335 | Arthur, III | Dec 1990 | A |
5001630 | Wiltfong | Mar 1991 | A |
5006699 | Felkner et al. | Apr 1991 | A |
5036462 | Kaufman et al. | Jul 1991 | A |
5036852 | Leishman | Aug 1991 | A |
5041086 | Koenig et al. | Aug 1991 | A |
5072383 | Brimm et al. | Dec 1991 | A |
5077666 | Brimm et al. | Dec 1991 | A |
5078683 | Sancoff et al. | Jan 1992 | A |
5088056 | McIntosh et al. | Feb 1992 | A |
5088981 | Howson et al. | Feb 1992 | A |
5100380 | Epstein et al. | Mar 1992 | A |
5126957 | Kaufman et al. | Jun 1992 | A |
5142484 | Kaufman et al. | Aug 1992 | A |
5153416 | Neeley | Oct 1992 | A |
5153827 | Coutre et al. | Oct 1992 | A |
5164575 | Neeley et al. | Nov 1992 | A |
5166498 | Neeley | Nov 1992 | A |
5171977 | Morrison | Dec 1992 | A |
5181910 | Scanlon | Jan 1993 | A |
5190522 | Wojcicki et al. | Mar 1993 | A |
5207642 | Orkin et al. | May 1993 | A |
5235507 | Sackler et al. | Aug 1993 | A |
5256157 | Samiotes et al. | Oct 1993 | A |
5258906 | Kroll et al. | Nov 1993 | A |
5265010 | Evans-Paganelli et al. | Nov 1993 | A |
5267174 | Kaufman et al. | Nov 1993 | A |
5291399 | Chaco | Mar 1994 | A |
5292029 | Pearson | Mar 1994 | A |
5307263 | Brown | Apr 1994 | A |
5312334 | Hara et al. | May 1994 | A |
5314243 | McDonald et al. | May 1994 | A |
5315505 | Pratt et al. | May 1994 | A |
5317506 | Coutre et al. | May 1994 | A |
H1324 | Dalke et al. | Jun 1994 | H |
5331547 | Laszlo | Jul 1994 | A |
5356378 | Doan | Oct 1994 | A |
5367555 | Isoyama | Nov 1994 | A |
5368554 | Nazarian et al. | Nov 1994 | A |
5371692 | Draeger et al. | Dec 1994 | A |
5374813 | Shipp | Dec 1994 | A |
5376070 | Purvis et al. | Dec 1994 | A |
5378231 | Johnson et al. | Jan 1995 | A |
5382232 | Hague et al. | Jan 1995 | A |
5390238 | Kirk et al. | Feb 1995 | A |
5401059 | Ferrario | Mar 1995 | A |
5404384 | Colburn et al. | Apr 1995 | A |
5408443 | Weinberger | Apr 1995 | A |
5412372 | Parkhurst et al. | May 1995 | A |
5412564 | Ecer | May 1995 | A |
5416695 | Stutman et al. | May 1995 | A |
5456691 | Snell | Oct 1995 | A |
5460605 | Tuttle et al. | Oct 1995 | A |
5465082 | Chaco | Nov 1995 | A |
5472614 | Rossi | Dec 1995 | A |
5502944 | Kraft et al. | Apr 1996 | A |
5515426 | Yacenda et al. | May 1996 | A |
5522798 | Johnson et al. | Jun 1996 | A |
5533079 | Colburn et al. | Jul 1996 | A |
5536084 | Curtis et al. | Jul 1996 | A |
5538006 | Heim et al. | Jul 1996 | A |
5542420 | Goldman et al. | Aug 1996 | A |
5544649 | David et al. | Aug 1996 | A |
5544661 | Davis et al. | Aug 1996 | A |
5547470 | Johnson et al. | Aug 1996 | A |
5561412 | Novak et al. | Oct 1996 | A |
5562232 | Pearson | Oct 1996 | A |
5564803 | McDonald et al. | Oct 1996 | A |
5573506 | Vasko | Nov 1996 | A |
5582593 | Hultman | Dec 1996 | A |
5583758 | McIlroy et al. | Dec 1996 | A |
5592374 | Fellagara et al. | Jan 1997 | A |
5594786 | Chaco | Jan 1997 | A |
5597995 | Williams et al. | Jan 1997 | A |
5601445 | Schipper et al. | Feb 1997 | A |
5622429 | Heinze | Apr 1997 | A |
5628309 | Brown | May 1997 | A |
5630710 | Tune et al. | May 1997 | A |
5633910 | Cohen | May 1997 | A |
5643212 | Coutre et al. | Jul 1997 | A |
5644778 | Burks et al. | Jul 1997 | A |
5645531 | Thompson et al. | Jul 1997 | A |
5651775 | Walker et al. | Jul 1997 | A |
5655118 | Heindel et al. | Aug 1997 | A |
5657236 | Conkright | Aug 1997 | A |
5658250 | Blomquist et al. | Aug 1997 | A |
5672154 | Sillen et al. | Sep 1997 | A |
5681285 | Ford et al. | Oct 1997 | A |
5683367 | Jordan et al. | Nov 1997 | A |
5685844 | Marttila | Nov 1997 | A |
5689229 | Chaco et al. | Nov 1997 | A |
5692640 | Caulfield et al. | Dec 1997 | A |
5699038 | Ulrich et al. | Dec 1997 | A |
5700998 | Palti | Dec 1997 | A |
5703786 | Conkright | Dec 1997 | A |
5704352 | Tremblay et al. | Jan 1998 | A |
5710551 | Ridgeway | Jan 1998 | A |
5712913 | Chaum | Jan 1998 | A |
5713856 | Eggers | Feb 1998 | A |
5721913 | Ackroff et al. | Feb 1998 | A |
5733259 | Valcke et al. | Mar 1998 | A |
5737539 | Edelson et al. | Apr 1998 | A |
5738102 | Lemelson | Apr 1998 | A |
5752235 | Kehr et al. | May 1998 | A |
5758095 | Albaum et al. | May 1998 | A |
5758096 | Barsky et al. | May 1998 | A |
5760704 | Barton et al. | Jun 1998 | A |
5764034 | Bowman et al. | Jun 1998 | A |
5772585 | Lavin et al. | Jun 1998 | A |
5774865 | Glynn | Jun 1998 | A |
5781442 | Engelson et al. | Jul 1998 | A |
5790409 | Fedor et al. | Aug 1998 | A |
5795327 | Wilson et al. | Aug 1998 | A |
5803906 | Pratt et al. | Sep 1998 | A |
5807321 | Stoker et al. | Sep 1998 | A |
5807336 | Russo et al. | Sep 1998 | A |
5819229 | Boppe | Oct 1998 | A |
5822418 | Yacenda et al. | Oct 1998 | A |
5822544 | Chaco et al. | Oct 1998 | A |
5832488 | Eberhardt | Nov 1998 | A |
5833599 | Schrier et al. | Nov 1998 | A |
5842173 | Strum et al. | Nov 1998 | A |
5842976 | Williamson | Dec 1998 | A |
5845253 | Rensimer et al. | Dec 1998 | A |
5845254 | Lockwood et al. | Dec 1998 | A |
5845255 | Mayaud | Dec 1998 | A |
5845264 | Nellhaus | Dec 1998 | A |
5848593 | McGrady et al. | Dec 1998 | A |
5850344 | Conkright | Dec 1998 | A |
5852408 | Christiansen et al. | Dec 1998 | A |
5855550 | Lai et al. | Jan 1999 | A |
5867821 | Ballantyne et al. | Feb 1999 | A |
5871465 | Vasko | Feb 1999 | A |
5883806 | Meador et al. | Mar 1999 | A |
5885245 | Lynch et al. | Mar 1999 | A |
5894273 | Meador et al. | Apr 1999 | A |
5895371 | Levitas et al. | Apr 1999 | A |
5985371 | Fujioka et al. | Apr 1999 | A |
5899998 | McGauley et al. | May 1999 | A |
5903211 | Flego et al. | May 1999 | A |
5905653 | Higham et al. | May 1999 | A |
5907490 | Oliver | May 1999 | A |
5911132 | Sloane | Jun 1999 | A |
5911687 | Sato et al. | Jun 1999 | A |
5912818 | McGrady et al. | Jun 1999 | A |
5920054 | Uber, III | Jun 1999 | A |
5920263 | Huttenhoff et al. | Jul 1999 | A |
5928329 | Clark et al. | Jul 1999 | A |
5930145 | Yuyama et al. | Jul 1999 | A |
5935099 | Peterson et al. | Aug 1999 | A |
5941710 | Lampotang et al. | Aug 1999 | A |
5942986 | Shabot et al. | Aug 1999 | A |
5950630 | Portwood et al. | Sep 1999 | A |
5950632 | Reber et al. | Sep 1999 | A |
5953099 | Walach | Sep 1999 | A |
5954641 | Kehr et al. | Sep 1999 | A |
5957885 | Bollish et al. | Sep 1999 | A |
5961036 | Michael et al. | Oct 1999 | A |
5961446 | Beller et al. | Oct 1999 | A |
5971593 | McGrady | Oct 1999 | A |
5995077 | Wilcox et al. | Nov 1999 | A |
5995937 | DeBusk et al. | Nov 1999 | A |
6000828 | Leet | Dec 1999 | A |
6003006 | Colella et al. | Dec 1999 | A |
6009333 | Chaco | Dec 1999 | A |
6017318 | Gauthier et al. | Jan 2000 | A |
6021392 | Lester et al. | Feb 2000 | A |
6024699 | Surwit et al. | Feb 2000 | A |
6032155 | de la Huerga | Feb 2000 | A |
6039251 | Holowko et al. | Mar 2000 | A |
6047203 | Sackner et al. | Apr 2000 | A |
6048087 | Laurent et al. | Apr 2000 | A |
6053887 | Levitas et al. | Apr 2000 | A |
6063026 | Schauss et al. | May 2000 | A |
6082776 | Feinberg | Jul 2000 | A |
6112182 | Akers et al. | Aug 2000 | A |
RE36871 | Epstein et al. | Sep 2000 | E |
6134582 | Kennedy | Oct 2000 | A |
6135949 | Russo et al. | Oct 2000 | A |
6202923 | Boyer et al. | Mar 2001 | B1 |
6228057 | Vasko | May 2001 | B1 |
6241704 | Peterson et al. | Jun 2001 | B1 |
6269340 | Ford et al. | Jul 2001 | B1 |
6282441 | Raymond et al. | Aug 2001 | B1 |
6290681 | Brown | Sep 2001 | B1 |
6292698 | Duffin et al. | Sep 2001 | B1 |
6302844 | Walker et al. | Oct 2001 | B1 |
6312378 | Bardy | Nov 2001 | B1 |
6314556 | DeBusk et al. | Nov 2001 | B1 |
6319200 | Lai et al. | Nov 2001 | B1 |
6322502 | Schoenberg et al. | Nov 2001 | B1 |
6338007 | Broadfield et al. | Jan 2002 | B1 |
6339732 | Phoon et al. | Jan 2002 | B1 |
6406426 | Reuss et al. | Jun 2002 | B1 |
6409684 | Wilk | Jun 2002 | B1 |
6421650 | Goetz et al. | Jul 2002 | B1 |
6493747 | Simmon et al. | Dec 2002 | B2 |
6519569 | White et al. | Feb 2003 | B1 |
6529892 | Lambert | Mar 2003 | B1 |
6540672 | Simonsen et al. | Apr 2003 | B1 |
6558352 | Hogan | May 2003 | B1 |
6571128 | Lebel et al. | May 2003 | B2 |
6581606 | Kutzko et al. | Jun 2003 | B2 |
6671563 | Engelson et al. | Dec 2003 | B1 |
6745764 | Hickle | Jun 2004 | B2 |
6757898 | Ilsen et al. | Jul 2004 | B1 |
6785589 | Eggenberger et al. | Aug 2004 | B2 |
6796956 | Hartlaub et al. | Sep 2004 | B2 |
6799149 | Hartlaub | Sep 2004 | B2 |
6847861 | Lunak et al. | Jan 2005 | B2 |
6856247 | Wallace | Feb 2005 | B1 |
6873268 | Lebel et al. | Mar 2005 | B2 |
6993402 | Klass et al. | Jan 2006 | B2 |
7034691 | Rapaport et al. | Apr 2006 | B1 |
7054844 | Fletcher et al. | May 2006 | B2 |
7060059 | Keith et al. | Jun 2006 | B2 |
7096072 | Engleson et al. | Aug 2006 | B2 |
7201734 | Hickle | Apr 2007 | B2 |
7204823 | Estes et al. | Apr 2007 | B2 |
7215991 | Besson et al. | May 2007 | B2 |
7229430 | Hickle et al. | Jun 2007 | B2 |
7230529 | Ketcherside, Jr. et al. | Jun 2007 | B2 |
7256708 | Rosenfeld et al. | Aug 2007 | B2 |
7263492 | Suresh et al. | Aug 2007 | B1 |
7379885 | Zakim | May 2008 | B1 |
7384420 | Dycus et al. | Jun 2008 | B2 |
7398183 | Holland | Jul 2008 | B2 |
7421709 | Watson et al. | Sep 2008 | B2 |
7433853 | Brockway et al. | Oct 2008 | B2 |
7471994 | Ford et al. | Dec 2008 | B2 |
7526769 | Watts, Jr. et al. | Apr 2009 | B2 |
7587415 | Guarav et al. | Sep 2009 | B2 |
7612679 | Fackler et al. | Nov 2009 | B1 |
7693697 | Westenskow et al. | Apr 2010 | B2 |
7769601 | Bleser et al. | Aug 2010 | B1 |
7771385 | Eggers et al. | Aug 2010 | B2 |
7771386 | Eggers et al. | Aug 2010 | B2 |
7776031 | Hartlaub et al. | Aug 2010 | B2 |
7787946 | Stahmann et al. | Aug 2010 | B2 |
7796045 | Spear et al. | Sep 2010 | B2 |
7835927 | Schlotterbeck et al. | Nov 2010 | B2 |
7847970 | McGrady | Dec 2010 | B1 |
7860583 | Condurso et al. | Dec 2010 | B2 |
7962544 | Torok et al. | Jun 2011 | B2 |
7970550 | Arakelyan et al. | Jun 2011 | B2 |
8005688 | Coffman et al. | Aug 2011 | B2 |
8024200 | Jennings et al. | Sep 2011 | B2 |
8160895 | Schmitt et al. | Apr 2012 | B2 |
8197437 | Kalafut et al. | Jun 2012 | B2 |
8291337 | Gannin et al. | Oct 2012 | B2 |
8340792 | Condurso et al. | Dec 2012 | B2 |
8630722 | Condurso et al. | Jan 2014 | B2 |
8689008 | Rangadass et al. | Apr 2014 | B2 |
8761906 | Condurso et al. | Jun 2014 | B2 |
10192193 | Glass | Jan 2019 | B1 |
10417758 | Alexander | Sep 2019 | B1 |
10692207 | Sandmann et al. | Jun 2020 | B2 |
20010037083 | Hartlaub et al. | Nov 2001 | A1 |
20010044731 | Coffman et al. | Nov 2001 | A1 |
20020010679 | Felsher | Jan 2002 | A1 |
20020016568 | Lebel et al. | Feb 2002 | A1 |
20020016923 | Knaus et al. | Feb 2002 | A1 |
20020022973 | Sun et al. | Feb 2002 | A1 |
20020026223 | Riff et al. | Feb 2002 | A1 |
20020035484 | McCormick | Mar 2002 | A1 |
20020038392 | De La Huerga | Mar 2002 | A1 |
20020042636 | Koshiol et al. | Apr 2002 | A1 |
20020046346 | Evans | Apr 2002 | A1 |
20020077849 | Baruch et al. | Jun 2002 | A1 |
20020087114 | Hartlaub | Jul 2002 | A1 |
20020116509 | De La Huerga | Aug 2002 | A1 |
20020120350 | Klass et al. | Aug 2002 | A1 |
20020169636 | Eggers | Nov 2002 | A1 |
20020198624 | Greenwald et al. | Dec 2002 | A1 |
20030009244 | Engleson et al. | Jan 2003 | A1 |
20030036683 | Kehr et al. | Feb 2003 | A1 |
20030045858 | Struys et al. | Mar 2003 | A1 |
20030051737 | Hickle et al. | Mar 2003 | A1 |
20030063524 | Niemiec et al. | Apr 2003 | A1 |
20030069481 | Hervy et al. | Apr 2003 | A1 |
20030105389 | Noonan et al. | Jun 2003 | A1 |
20030105555 | Lunak et al. | Jun 2003 | A1 |
20030106553 | Vanderveen | Jun 2003 | A1 |
20030114836 | Estes et al. | Jun 2003 | A1 |
20030121517 | McFarland | Jul 2003 | A1 |
20030129578 | Mault | Jul 2003 | A1 |
20030135087 | Hickle et al. | Jul 2003 | A1 |
20030135388 | Martucci et al. | Jul 2003 | A1 |
20030139701 | White et al. | Jul 2003 | A1 |
20030140928 | Bui et al. | Jul 2003 | A1 |
20030140929 | Wilkes et al. | Jul 2003 | A1 |
20030149599 | Goodall et al. | Aug 2003 | A1 |
20030156143 | Westenskow et al. | Aug 2003 | A1 |
20030158746 | Forrester | Aug 2003 | A1 |
20030163223 | Blomguist | Aug 2003 | A1 |
20030205897 | Kaufman | Nov 2003 | A1 |
20030236683 | Henderson et al. | Dec 2003 | A1 |
20040068229 | Jansen et al. | Apr 2004 | A1 |
20040073329 | Engleson et al. | Apr 2004 | A1 |
20040107118 | Harnsberger et al. | Jun 2004 | A1 |
20040122702 | Sabol et al. | Jun 2004 | A1 |
20040122705 | Sabol et al. | Jun 2004 | A1 |
20040122719 | Sabol et al. | Jun 2004 | A1 |
20040122790 | Walker et al. | Jun 2004 | A1 |
20040128162 | Schlotterbeck et al. | Jul 2004 | A1 |
20040152622 | Keith et al. | Aug 2004 | A1 |
20040167465 | Mihai et al. | Aug 2004 | A1 |
20040167804 | Simpson et al. | Aug 2004 | A1 |
20040172283 | Vanderveen et al. | Sep 2004 | A1 |
20040172300 | Mihai et al. | Sep 2004 | A1 |
20040172302 | Martucci et al. | Sep 2004 | A1 |
20040176297 | Cheung et al. | Sep 2004 | A1 |
20040188998 | Henthorn | Sep 2004 | A1 |
20040193325 | Bonderud et al. | Sep 2004 | A1 |
20040193446 | Mayer et al. | Sep 2004 | A1 |
20040260478 | Schwamm | Dec 2004 | A1 |
20050010166 | Hickle | Jan 2005 | A1 |
20050010269 | Lebel et al. | Jan 2005 | A1 |
20050020996 | Hartlaub et al. | Jan 2005 | A1 |
20050021297 | Hartlaub | Jan 2005 | A1 |
20050022274 | Campbell et al. | Jan 2005 | A1 |
20050033606 | Miller | Feb 2005 | A1 |
20050049179 | Davidson et al. | Mar 2005 | A1 |
20050055242 | Bello et al. | Mar 2005 | A1 |
20050088296 | Lee | Apr 2005 | A1 |
20050096941 | Tong | May 2005 | A1 |
20050097566 | Watts et al. | May 2005 | A1 |
20050107914 | Engleson et al. | May 2005 | A1 |
20050108057 | Cohen et al. | May 2005 | A1 |
20050113945 | Engleson et al. | May 2005 | A1 |
20050119788 | Engleson et al. | Jun 2005 | A1 |
20050144043 | Holland et al. | Jun 2005 | A1 |
20050145010 | Vanderveen et al. | Jul 2005 | A1 |
20050148890 | Hastings | Jul 2005 | A1 |
20050171815 | Vanderveen | Aug 2005 | A1 |
20050224083 | Crass et al. | Oct 2005 | A1 |
20050278194 | Holland et al. | Dec 2005 | A1 |
20060026205 | Butterfield | Feb 2006 | A1 |
20060047538 | Condurso et al. | Mar 2006 | A1 |
20060053036 | Coffman et al. | Mar 2006 | A1 |
20060079831 | Gilbert | Apr 2006 | A1 |
20060101072 | Busche et al. | May 2006 | A1 |
20060122481 | Sievenpiper et al. | Jun 2006 | A1 |
20060190302 | Eggers et al. | Aug 2006 | A1 |
20060200369 | Batch et al. | Sep 2006 | A1 |
20060206356 | Vanderveen | Sep 2006 | A1 |
20060217628 | Huiku | Sep 2006 | A1 |
20060218015 | Walker et al. | Sep 2006 | A1 |
20060229551 | Martinez et al. | Oct 2006 | A1 |
20060249423 | Reijonen | Nov 2006 | A1 |
20060271401 | Lassetter et al. | Nov 2006 | A1 |
20060287890 | Stead et al. | Dec 2006 | A1 |
20070015972 | Wang et al. | Jan 2007 | A1 |
20070043767 | Osborne et al. | Feb 2007 | A1 |
20070061266 | Moore et al. | Mar 2007 | A1 |
20070061393 | Moore | Mar 2007 | A1 |
20070083389 | Dyer et al. | Apr 2007 | A1 |
20070106457 | Rosenberg | May 2007 | A1 |
20070106753 | Moore | May 2007 | A1 |
20070106754 | Moore | May 2007 | A1 |
20070129647 | Lynn | Jun 2007 | A1 |
20070156452 | Batch | Jul 2007 | A1 |
20070156860 | Nedelcu et al. | Jul 2007 | A1 |
20070168301 | Eisner et al. | Jul 2007 | A1 |
20070208454 | Forrester et al. | Sep 2007 | A1 |
20070210157 | Miller | Sep 2007 | A1 |
20070286466 | Heffernan et al. | Dec 2007 | A1 |
20070293843 | Ireland et al. | Dec 2007 | A1 |
20080015549 | Maughan | Jan 2008 | A1 |
20080025230 | Patel et al. | Jan 2008 | A1 |
20080034323 | Blomquist | Feb 2008 | A1 |
20080040151 | Moore | Feb 2008 | A1 |
20080046292 | Myers et al. | Feb 2008 | A1 |
20080141272 | Borgendale et al. | Jun 2008 | A1 |
20080162254 | Herger et al. | Jul 2008 | A1 |
20080164998 | Scherpbier et al. | Jul 2008 | A1 |
20080169045 | Tribble et al. | Jul 2008 | A1 |
20080195246 | Tribble et al. | Aug 2008 | A1 |
20080272138 | Ross et al. | Nov 2008 | A1 |
20080317672 | Viertio-Oja | Dec 2008 | A1 |
20090012812 | Rausch et al. | Jan 2009 | A1 |
20090012813 | Berzansky et al. | Jan 2009 | A1 |
20090043253 | Podaima | Feb 2009 | A1 |
20090054754 | McMahon et al. | Feb 2009 | A1 |
20090062727 | Woo | Mar 2009 | A1 |
20090099867 | Newman | Apr 2009 | A1 |
20090112333 | Sahai | Apr 2009 | A1 |
20090125335 | Manetta et al. | May 2009 | A1 |
20090150484 | Roberts | Jun 2009 | A1 |
20090210252 | Silver | Aug 2009 | A1 |
20090240651 | Fletcher et al. | Sep 2009 | A1 |
20090306585 | Pang et al. | Dec 2009 | A1 |
20090306944 | Willmann et al. | Dec 2009 | A1 |
20090319623 | Srinivasan et al. | Dec 2009 | A1 |
20100037067 | Rangadass et al. | Feb 2010 | A1 |
20100094653 | Tribble et al. | Apr 2010 | A1 |
20100121654 | Portnoy et al. | May 2010 | A1 |
20100161113 | Tribble et al. | Jun 2010 | A1 |
20100169120 | Herbst et al. | Jul 2010 | A1 |
20100169771 | Pelegrin et al. | Jul 2010 | A1 |
20100174552 | Hawkes et al. | Jul 2010 | A1 |
20100174553 | Kaufman et al. | Jul 2010 | A1 |
20100179825 | Hanov et al. | Jul 2010 | A1 |
20100241453 | Malec | Sep 2010 | A1 |
20100241456 | Miller et al. | Sep 2010 | A1 |
20100271218 | Hoag et al. | Oct 2010 | A1 |
20100280840 | Fukushi et al. | Nov 2010 | A1 |
20100323397 | Reavy et al. | Dec 2010 | A1 |
20110015941 | Backhaus | Jan 2011 | A1 |
20110046975 | Hoffman | Feb 2011 | A1 |
20110060758 | Schlotterbeck et al. | Mar 2011 | A1 |
20110078608 | Gannon et al. | Mar 2011 | A1 |
20110119612 | Gannon et al. | May 2011 | A1 |
20110179405 | Dicks et al. | Jul 2011 | A1 |
20110202495 | Gawlick | Aug 2011 | A1 |
20110282691 | Coffman et al. | Nov 2011 | A1 |
20110288882 | Halow | Nov 2011 | A1 |
20110313787 | Rangadass et al. | Dec 2011 | A1 |
20120011253 | Friedman et al. | Jan 2012 | A1 |
20120016215 | Condurso et al. | Jan 2012 | A1 |
20120041775 | Cosentino et al. | Feb 2012 | A1 |
20120053533 | Butterfield et al. | Mar 2012 | A1 |
20120075060 | Connor | Mar 2012 | A1 |
20120075061 | Barnes | Mar 2012 | A1 |
20120136673 | Presley et al. | May 2012 | A1 |
20120173264 | Brush et al. | Jul 2012 | A1 |
20120173391 | Korhnak et al. | Jul 2012 | A1 |
20120179006 | Jansen et al. | Jul 2012 | A1 |
20120182939 | Rajan et al. | Jul 2012 | A1 |
20120185267 | Kamen et al. | Jul 2012 | A1 |
20120191052 | Rao | Jul 2012 | A1 |
20120239824 | Nguyen et al. | Sep 2012 | A1 |
20120241043 | Perazzo | Sep 2012 | A1 |
20120247480 | Varga | Oct 2012 | A1 |
20120253835 | Tracy et al. | Oct 2012 | A1 |
20120265549 | Virolainen | Oct 2012 | A1 |
20130018356 | Prince et al. | Jan 2013 | A1 |
20130085771 | Ghanbari et al. | Apr 2013 | A1 |
20130096444 | Condurso et al. | Apr 2013 | A1 |
20130197927 | Vanderveen et al. | Aug 2013 | A1 |
20130197928 | Vanderveen et al. | Aug 2013 | A1 |
20130197929 | Vanderveen et al. | Aug 2013 | A1 |
20130197930 | Garibaldi et al. | Aug 2013 | A1 |
20130197931 | Gupta et al. | Aug 2013 | A1 |
20130204433 | Gupta et al. | Aug 2013 | A1 |
20130204637 | Vanderveen et al. | Aug 2013 | A1 |
20130262138 | Jaskela et al. | Oct 2013 | A1 |
20140028464 | Garibaldi | Jan 2014 | A1 |
20140100868 | Condurso et al. | Apr 2014 | A1 |
20140278466 | Simmons et al. | Sep 2014 | A1 |
20140297313 | Condurso et al. | Oct 2014 | A1 |
20140350950 | Jaskela et al. | Nov 2014 | A1 |
20150250948 | Gupta et al. | Sep 2015 | A1 |
20160000997 | Batch et al. | Jan 2016 | A1 |
20160114925 | Yuyama | Apr 2016 | A1 |
Number | Date | Country |
---|---|---|
2472098 | Jul 2003 | CA |
2554903 | Apr 2005 | CA |
1421810 | Jun 2003 | CN |
1650317 | Aug 2005 | CN |
1759398 | Apr 2006 | CN |
1803103 | Jul 2006 | CN |
101116077 | Jan 2008 | CN |
101146055 | Mar 2008 | CN |
201110955 | Sep 2008 | CN |
101331491 | Dec 2008 | CN |
101689320 | Mar 2010 | CN |
101890193 | Nov 2010 | CN |
102068725 | May 2011 | CN |
102508877 | Jun 2012 | CN |
102521394 | Jun 2012 | CN |
102688532 | Sep 2012 | CN |
102799783 | Nov 2012 | CN |
4023785 | Jan 1992 | DE |
0192786 | Sep 1986 | EP |
0384155 | Aug 1990 | EP |
0595474 | May 1994 | EP |
0649316 | Apr 1995 | EP |
0652528 | May 1995 | EP |
0784283 | Jul 1997 | EP |
0921488 | Jun 1999 | EP |
1003121 | May 2000 | EP |
1018347 | Jul 2000 | EP |
1237113 | Sep 2002 | EP |
1750573 | Feb 2007 | EP |
2141006 | Dec 1984 | GB |
62114562 | May 1987 | JP |
5168708 | Jul 1993 | JP |
11505352 | May 1999 | JP |
2002520718 | Jul 2002 | JP |
2003085283 | Mar 2003 | JP |
2004287616 | Oct 2004 | JP |
2005165442 | Jun 2005 | JP |
2005296428 | Oct 2005 | JP |
2006155070 | Jun 2006 | JP |
2006521183 | Sep 2006 | JP |
2008508616 | Mar 2008 | JP |
2008516303 | May 2008 | JP |
2011501311 | Jan 2011 | JP |
2012200430 | Oct 2012 | JP |
1020070045611 | May 2007 | KR |
1020080013129 | Feb 2008 | KR |
100847397 | Jul 2008 | KR |
1020100125972 | Dec 2010 | KR |
1020110070824 | Jun 2011 | KR |
1020120076615 | Jul 2012 | KR |
1020120076635 | Jul 2012 | KR |
522631 | Jul 2004 | NZ |
WO-1993022735 | Nov 1993 | WO |
WO-1994005344 | Mar 1994 | WO |
WO-1994008647 | Apr 1994 | WO |
WO-1994013250 | Jun 1994 | WO |
WO-1995023378 | Aug 1995 | WO |
WO-1996020745 | Jul 1996 | WO |
WO-1996025214 | Aug 1996 | WO |
WO-1996036923 | Nov 1996 | WO |
WO-1997004712 | Feb 1997 | WO |
WO-1998013783 | Apr 1998 | WO |
WO-1998028676 | Jul 1998 | WO |
WO-1999009505 | Feb 1999 | WO |
WO-1999010829 | Mar 1999 | WO |
WO-1999010830 | Mar 1999 | WO |
WO1999035588 | Jul 1999 | WO |
WO-1999044167 | Sep 1999 | WO |
WO-1999045490 | Sep 1999 | WO |
WO-1999046718 | Sep 1999 | WO |
WO-1999067732 | Dec 1999 | WO |
WO-2000003344 | Jan 2000 | WO |
WO-2000004521 | Jan 2000 | WO |
WO-2000018449 | Apr 2000 | WO |
WO-2000032088 | Jun 2000 | WO |
WO-2000032098 | Jun 2000 | WO |
WO-2001086506 | Nov 2001 | WO |
WO-2001088828 | Nov 2001 | WO |
WO-2002036044 | May 2002 | WO |
WO-2002069099 | Sep 2002 | WO |
WO-2003038566 | May 2003 | WO |
WO-2003053503 | Jul 2003 | WO |
WO-2003092769 | Nov 2003 | WO |
WO-2003094091 | Nov 2003 | WO |
WO-2004060443 | Jul 2004 | WO |
WO-2004061745 | Jul 2004 | WO |
WO-2002053209 | Oct 2004 | WO |
WO-2005110208 | Nov 2005 | WO |
WO-2008087982 | May 2010 | WO |
WO-2010124016 | Oct 2010 | WO |
WO-2010124328 | Nov 2010 | WO |
WO-2012095829 | Jul 2012 | WO |
WO-2014159280 | Oct 2014 | WO |
Entry |
---|
Brazilian Office Action for Application No. BR112015029135-0, dated Aug. 30, 2022, 10 pages including translation. |
Canadian Office Action for Application No. 2901024, dated Jul. 20, 2022, 5 pages. |
Chinese Office Action for Application No. 202111564727.9, dated Aug. 17, 2022, 14 pages including translation. |
Brazilian Office Action for Application No. BR112015029135-0, dated Mar. 8, 2022, 8 pages including translation. |
Chinese Office Action for Application No. 201480015093.3, dated Mar. 3, 2022, 42 pages including translation. |
“General-Purpose Infusion Pumps,” Evaluation—Health Devices, Oct. 2002, pp. 353-387, vol. 31 (10), ECRI Institute. |
“Infusion Pump Technology,” Health Devices, Apr.-May 1998, pp. 150-170, vol. 27(4-5), ECRI Institute. |
“Infusion Pumps, General Purpose,” Healthcare Product Comparison System, 2007, pp. 1-54, ECRI Institute. |
“Infusion Pumps, Large-Volume,” Healthcare Product Comparison System, 2010, pp. 1-51, ECRI Institute. |
“Smart Infusion Pumps Join CPOE and Bar Coding as Important Ways to Prevent Medication Errors,” ISMP—Medication Safety Alert, Feb. 7, 2002, 2 pgs., Institute for Safe Medication Practices. |
Anonymous, Guardrails® Safety Software—Medley TM Medication Safety System, Alaris Medical Systems XP-00234431; 2002 Alaris Medical Systems Inc. Nov. 2002, SSM @2159C. |
Australia Office Action for Application No. 2014268828, dated Jul. 3, 2020, 5 pages. |
Australian Decision Issued for Application No. 2014268828, dated Feb. 26, 2021,30 pages. |
Australian Examination Report No. 1 for Application No. 2016216550, dated Sep. 20, 2017, 3 pages. |
Australian Examination Report No. 2 for Application No. 2012228997, dated Dec. 11, 2015, 3 pages. |
Australian Office Action for Application No. 2006213718, dated Jul. 8, 2010, 4 pages. |
Australian Office Action for Application No. 2006213718, dated Sep. 19, 2011, 3 pages. |
Australian Office Action for Application No. 2014241019, dated Aug. 12, 2019, 4 pages. |
Australian Office Action for Application No. 2014241019, dated Dec. 5, 2019, 5 pages. |
Australian Office Action for Application No. 2014241019, dated Feb. 6, 2019, 3 pages. |
Australian Office Action for Application No. 2014241022, dated Feb. 7, 2019, 4 pages. |
Australian Office Action for Application No. 2014241022, dated Jun. 25, 2019, 3 pages. |
Australian Office Action for Application No. 2014241022, dated Sep. 30, 2019, 4 pages. |
Australian Office Action for Application No. 2014268828, dated Jul. 26, 2019, 4 pages. |
Australian Office Action for Application No. 2014268828, dated Nov. 25, 2019, 3 pages. |
Australian Office Action for Application No. 2018232958, dated Aug. 7, 2019, 3 pages. |
Australian Office Action for Application No. 2020200812, dated Mar. 24, 2021, 5 pages. |
Australian Office Action for Application No. 2020201641, dated Oct. 9, 2020, 4 pages. |
Australian Office Action for Application No. 2020203449, dated May 26, 2021, 5 pages. |
Baldauf-Sobez et al., “How Siemens' Computerized Physician Order Entry Helps Prevent the Human Errors,” electromedica, vol. 71, No. 1, 2003, pp. 2-10. |
Brazil Office Action for Application No. BR112015019758-2, dated Feb. 20, 2020, 5 pages. |
Brazil Office Action for Application No. BR112015029135-0, dated Feb. 12, 2020, 5 pages. |
Calabrese, et al., “Medication administration errors in adult patients in the ICU,” Intensive Care Med, 2001, pp. 1592-1598, vol. 27, Springer-Verlag. |
Canada Office Action for Application No. 2900564, dated Jan. 28, 2020, 4 pages. |
Canadian Office Action for Application No. 2512991, dated Jan. 10, 2018, 4 pages. |
Canadian Office Action for Application No. 2512991, dated Mar. 2, 2017, 4 pages. |
Canadian Office Action for Application No. 2551903, dated Aug. 18, 2020, 3 pages. |
Canadian Office Action for Application No. 2551903, dated Mar. 28, 2017, 7 pages. |
Canadian Office Action for Application No. 2551903, dated Mar. 5, 2018, 8 pages. |
Canadian Office Action for Application No. 2596881, dated Dec. 20, 2012, 1 page. |
Canadian Office Action for Application No. 2828898, dated Aug. 25, 2021, 5 pages. |
Canadian Office Action for Application No. 2828898, dated Dec. 3, 2019, 6 pages. |
Canadian Office Action for Application No. 2828898, dated Dec. 7, 2018, 5 pages. |
Canadian Office Action for Application No. 2828898, dated Jan. 11, 2018, 8 pages. |
Canadian Office Action for Application No. 2828898, dated Oct. 7, 2020, 7 pages. |
Canadian Office Action for Application No. 2900564, dated Nov. 19, 2020, 4 pages. |
Canadian Office Action for Application No. 2901024, dated Aug. 25, 2021, 6 pages. |
Canadian Office Action for Application No. 2901024, dated Jan. 27, 2020, 5 pages. |
Canadian Office Action for Application No. 2901024, dated Nov. 20, 2020, 6 pages. |
Canadian Office Action for Application No. 2912792, dated Mar. 1, 2021, 7 pages. |
Chinese First Office Action for Application No. 2012800136388, dated Jul. 23, 2015, 15 pages. |
Chinese Notice of Reexamination for Application No. 201480015025.7, dated Aug. 20, 2021, 29 pages including translation. |
Chinese Notice of Reexamination for Application No. 201480015036.5, dated Jul. 29, 2021, 32 pages including machine translation. |
Chinese Office Action for Application No. 2 1480041362.3, dated Oct. 18, 2018, 13 pages. |
Chinese Office Action for Application No. 2012800136388, dated Jul. 18, 2016, 2 pages excluding machine translation. |
Chinese Office Action for Application No. 201480015025.7, dated Jan. 23, 2018, 11 pages excluding English summary. |
Chinese Office Action for Application No. 201480015025.7, dated Jun. 24, 2019, 25 pages. |
Chinese Office Action for Application No. 201480015025.7, dated Nov. 12, 2019, 20 pages. |
Chinese Office Action for Application No. 201480015025.7, dated Oct. 9, 2018, 27 pages. |
Chinese Office Action for Application No. 201480015036.5, dated Jan. 23, 2018, 13 pages excluding English translation. |
Chinese Office Action for Application No. 201480015036.5, dated Jun. 24, 2019, 20 pages. |
Chinese Office Action for Application No. 201480015036.5, dated Nov. 5, 2019, 12 pages. |
Chinese Office Action for Application No. 201480015036.5, dated Sep. 29, 2018, 20 pages. |
Chinese Office Action for Application No. 201480015093.3, dated Apr. 25, 2019, 18 pages. |
Chinese Office Action for Application No. 201480015093.3, dated Dec. 4, 2019, 17 pages. |
Chinese Office Action for Application No. 201480015093.3, dated Jul. 16, 2018, 16 pages. |
Chinese Office Action for Application No. 201480015147.6, dated Mar. 10, 2017, 10 pages excluding translation. |
Chinese Office Action for Application No. 201480015147.6, dated May 3, 2018, 6 pages. |
Chinese Office Action for Application No. 201480015147.6, dated Nov. 16, 2017, 8 pages. |
Chinese Office Action for Application No. 201480041985.0, dated Apr. 3, 2019, 12 pages. |
Chinese Office Action for Application No. 201480041985.0, dated Jun. 2, 2021, 4 pages including translation. |
Chinese Office Action for Application No. 201480041985.0, dated May 15, 2020, 23 pages. |
Chinese Office Action for Application No. 201480041985.0, dated Sep. 23, 2019, 24 pages. |
Chinese Office Action for Application No. 201480041985.0, dated Sep. 3, 2020, 38 pages. |
Chinese Second Office Action for Application No. 201280013638.8, dated Feb. 15, 2016, 8 pages excluding translation. |
Eskew, James et al., Using Innovative Technologies To Set New Safety Standards For The Infusion Of Intravenous Medications, Hospital Pharmacy, vol. 37, No. 11, pp. 1179-1189, 2002, Facts and Comparisons. |
European Communication for Application No. 14779655.1, dated Oct. 2, 2019, 12 pages. |
European Communication of the Board of Appeal for Application No. 05791269.3, dated Nov. 10, 2017, 7 pages. |
European Office Action for Application No. 06720651.6, dated May 5, 2008, 3 pages. |
European Office Action for Application No. 12756903.6, dated Apr. 19, 2017, 5 pages. |
European Office Action for Application No. 14772937.0, dated Apr. 19, 2018, 9 pages. |
European Office Action for Application No. 14775918.7, dated Dec. 20, 2017, 8 pages. |
European Office Action for Application No. 14779655.1, dated Jul. 28, 2017, 6 pages. |
European Office Action for Application No. 14779655.1, dated Mar. 8, 2018, 7 pages. |
European Office Action for Application No. 14801713.0, dated Dec. 11, 2019, 6 pages. |
European Office Action for Application No. 20191537.8, dated Aug. 18, 2021, 10 pages. |
European Summons to attend oral proceedings pursuant to Rule 115(1) EPC for Application No. 14772937.0, dated Jul. 17, 2019, 12 pages. |
Evans, R. S. et al., “Enhanced notification of infusion pump programming errors”, Studies in health technology and informatics, Jan. 1, 2010, pp. 734-738, XP055305644, Netherlands DOI: 10.3233/978-1-60750-588-4-734 Retrieved from the Internet: URL:http://booksonline.iospress.nl/Extern/EnterMedLine.aspx?ISSN=0926-9630&Volume=160&SPage=734 [retrieved on Sep. 26, 2016]. |
Extended European Search Report and Written Opinion for Application No. 14772937.0, dated Oct. 10, 2016, 9 pages. |
Extended European Search Report and Written Opinion for Application No. 14775918.7, dated Sep. 13, 2016, 10 pages. |
Extended European Search Report and Written Opinion for Application No. 14779139.6, dated Nov. 7, 2016, 7 pages. |
Extended European Search Report for Application No. 14779655.1, dated Jul. 14, 2016, 8 pages. |
Extended European Search Report for Application No. 14780320.9, dated Jul. 1, 2016, 7 pages. |
Extended European Search Report for Application No. 14801713.0, dated Jan. 16, 2017, 8 pages. |
Extended European Search Report for Application No. 14801726.2, dated Jan. 5, 2017, 8 pages. |
Extended European Search Report for Application No. 20191537.8, dated Dec. 17, 2020, 9 pages. |
Hickle, WO 2004/060443, Appartuses and Method for Automatically Assessing and Monitoring a Patient's Responsiveness, Dec. 23, 2003. |
India Office Action for Application No. 2625/KOLNP/2015, dated Jul. 8, 2020, 7 pages. |
India Office Action for Application No. 4041/KOLNP/2015, dated Jul. 8, 2020, 8 pages. |
India Office Action for Application No. 7050/CHENP/2013, dated Sep. 18, 2019, 7 pages. |
International Preliminary Report on Patentability for Application No. PCT/US2004/000443, dated Nov. 30, 2004, 3 pages. |
International Search Report and Written Opinion for Application No. PCT/US2004/043531, dated Sep. 22, 2005, 12 pages. |
International Search Report and Written Opinion for Application No. PCT/US2005/029993, dated Jan. 23, 2006, 17 pages. |
International Search Report and Written Opinion for Application No. PCT/US2013/029993, dated Feb. 4, 2014, 9 pages. |
International Search Report and Written Opinion for Application No. PCT/US2014/023681, dated Jul. 14, 2014, 12 pages. |
International Search Report and Written Opinion for PCT Application No. PCT/US2014/022830, dated Jun. 19, 2014, 6 pages. |
International Search Report and Written Opinion for PCT Application No. PCT/US2014/022832, dated Jun. 24, 2014, 5 pages. |
International Search Report and Written Opinion for PCT Application No. PCT/US2014/022835. |
International Search Report and Written Opinion for PCT Application No. PCT/US2014/022837, dated Jun. 18, 2014. |
International Search Report and Written Opinion for PCT Application No. PCT/US2014/022840, dated Jun. 19, 2014, 5 pages. |
International Search Report and Written Opinion for PCT Application No. PCT/US2014/037577 dated Sep. 5, 2014. |
International Search Report and Written Opinion for PCT/US2012/029544 dated Sep. 28, 2012, 8 pages. |
International Search Report and Written Opinion in PCT Application No. PCT/US2014/039228 dated Aug. 22, 2014, 11 pgs. |
International Search Report for Application No. PCT/US2001/15989, dated Nov. 28, 2002, 3 pages. |
International Search Report for Application No. PCT/US2014/023685, dated Jul. 9, 2014, 4 pages. |
International Search Report for Application No. PCT/US2014/038497, dated Oct. 23, 2014, 3 pages. |
International Search Report for PCT Application No. PCT/US2004/000443 dated Sep. 1, 2004. |
International Search Report for PCT Application No. PCT/US2006/004864. |
Japanese Office Action for Application No. 2016-501081, dated May 7, 2019, 4 pages. |
Japanese Office Action for Application No. 2016501081, dated Nov. 12, 2019, 6 pages. |
Japanese Office Action for Application No. 2016-501081, dated Nov. 2, 2018, 6 pages. |
Japanese Office Action for Application No. 2019-030891, dated Aug. 24, 2021, 4 pages including translation. |
Japanese Office Action for Application No. 2019-030891, dated May 27, 2020, 8 pages. |
Japanese Office Action for Application No. 2019-030891, dated Nov. 26, 2020, 5 pages including English translation. |
Japanese Office Action in Application No. 2016-501081, dated Feb. 9, 2018, 4 pages. |
Japanese Office Action in JP Application No. 2004-565078 dated Aug. 3, 2009. |
Kohn, et al., “To Err is Human—Building a Safer Health System,” National Academy Press, 2002, pp. i-i287, National Academy of Sciences. |
Lesar, “Recommendations for Reducing Medication Errors,” Medscape Pharmacists, posted Jul. 24, 2000, 10 pgs, vol. 1(2), Medscape Pharmacists, <http://www.medscape.com>. |
Meier, “Hospital Products Get Seal of Approval at a Price,” The New York Times, Apr. 23, 2002, 5 pgs. |
Memo concerning Mexican Office Action for Application No. MX/a/2015/015959, dated Sep. 21, 2017, 4 pages. |
Memo concerning Mexican Office Action for Application No. MX/a/2015/015959, dated Mar. 2, 2018, 1 page. |
New Zealand Examination Report for Application No. 560278, dated Jun. 23, 2009, 1 page. |
Non-Final Office Action dated Oct. 14, 2014, issued in U.S. Appl. No. 11/326,145. |
Non-Final Office Action dated Oct. 14, 2014, issued in U.S. Appl. No. 13/559,537. |
Office Action dated Aug. 19, 2013; issued in U.S. Appl. No. 13/246,782. |
Office Action for U.S. Appl. No. 09/860,865 dated Jul. 25, 2014. |
Office Action for U.S. Appl. No. 13/802,433. |
Office Action for U.S. Appl. No. 13/802,683. |
Office Action for UAE Application No. UAE/P/353/2002 dated Jan. 25, 2011. |
Office Action for United Arab Emirates Application No. UAE/P/0962/2013, dated Apr. 17, 2017, 18 pages. |
Office Action issued in U.S. Appl. No. 13/802,446 dated Aug. 13, 2014. |
Queensland Health. Use of returned or unused dispensed medicines, Jan. 5, 2005, Queensland Government. pp. 1-2. |
Shabot et al., “Wireless clinical alerts for critical medication, laboratory and physiologic data,” System Sciences 2000. Proceedings of the 33rd Annual Conference on Jan. 4-7, 2000, Piscataway, NJ, IEEE, Jan. 4, 2000. |
Translation of Japanese Office Action in JP Application No. 2006547436 dated Apr. 1, 2011. |
U.S. Appl. No. 90/009,912, filed Aug. 12, 2013, Schlotterbeck et al. |
U.S. Appl. No. 90/011,697, filed Aug. 12, 2013, Schlotterbeck et al. |
United Arab Emirates Office Action from KIPO for Application No. UAE/P/1554/2015, first received Nov. 21, 2019, 11 pages. |
U.S. Office Action in U.S. Appl. No. 13/421,776 dated Oct. 9, 2013, 35 pages. |
U.S. Appl. No. 13/901,501, filed May 23, 2013. |
Williams, et al., “Reducing the Risk of User Error with Infusion Pumps,” Professional Nurse—Safe Practice—Infusion Devices, Mar. 2000, pp. 382-384, vol. 15(6). |
Written Opinion for Application No. PCT/US2004/000443, dated Jun. 22, 2005, 5 pages. |
Written Opinion for Application No. PCT/US2006/004864, dated Jun. 22, 2006, 5 pages. |
Yokoi, “Prevention of Errors in Injection/Drip Infusion—No excuse for ignorance!—Essential Points of Accident Prevention, IV Infusion Pump, Syringe-pump Accident Prevention,” JIN Special, Igaku Shoin K.K., Dec. 1, 2001, pp. 109-120, No. 70. |
Australian Office Action for Application No. 2020200812, dated Nov. 18, 2021, 4 pages. |
Canadian Office Action for Application No. 2912792, dated Dec. 30, 2021, 9 pages. |
Australian Office Action for Application No. 2020203449, dated Nov. 24, 2021, 3 pages. |
Australian Office Action for Application No. 2020210162, dated Sep. 22, 2021, 6 pages. |
Chinese Office Action for Application No. 201480015036.5, dated Sep. 24, 2021, 52 pages including translation. |
Chinese Office Action for Application No. 201480015093.3, dated Nov. 1, 2021, 36 pages including translation. |
Australian Office Action for Application No. 2022201089, dated Mar. 17, 2023, 3 pages. |
Chinese Office Action for Application No. 202111564727.9, dated Mar. 19, 2023, 14 pages including translation. |
Extended European Search Report for Application No. 22205566.7, dated Mar. 13, 2023, 12 pages. |
India Hearing Notice for Application No. 4041/KOLNP/2015, dated Apr. 6, 2023, 5 pages. |
Chinese Office Action for Application No. 202111564727.9, dated Aug. 2, 2023, 12 pages including translation. |
Number | Date | Country | |
---|---|---|---|
20210366600 A1 | Nov 2021 | US |
Number | Date | Country | |
---|---|---|---|
60205125 | May 2000 | US | |
60652382 | Feb 2005 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 13802446 | Mar 2013 | US |
Child | 17397866 | US | |
Parent | 12947773 | Nov 2010 | US |
Child | 13246782 | US | |
Parent | 10925511 | Aug 2004 | US |
Child | 12947773 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 09860865 | May 2001 | US |
Child | 13802446 | US | |
Parent | 10361704 | Feb 2003 | US |
Child | 13802446 | US | |
Parent | 10750032 | Dec 2003 | US |
Child | 10361704 | US | |
Parent | 13246782 | Sep 2011 | US |
Child | 10750032 | US | |
Parent | 11326145 | Dec 2005 | US |
Child | 13802446 | US |